BIRPro

Fuentes

Las 1.061 fuentes con las que se ha redactado y verificado el contenido: guías clínicas, revisiones y datos oficiales, ordenadas por libro y capítulo.

Bioquímica, Molecular y Genética

250 fuentes · 5 capítulos

Obras generales de referencia11
  1. Nelson DL, Cox MM, Hoskins AA. Lehninger principles of biochemistry. 8th ed. Nueva York: Macmillan Learning; 2021.
  2. Berg JM, Gatto GJ Jr, Hines JK, Tymoczko JL, Stryer L. Biochemistry. 10th ed. Nueva York: Macmillan Learning; 2023.
  3. Kennelly PJ, Botham KM, McGuinness OP, Weil PA. Harper's illustrated biochemistry. 33rd ed. Nueva York: McGraw Hill; 2026.
  4. Saudubray JM, Baumgartner MR, García-Cazorla Á, Walter J, editores. Inborn metabolic diseases: diagnosis and treatment. 7th ed. Berlín: Springer; 2022.
  5. Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, editores. Tietz textbook of laboratory medicine. 7th ed. St. Louis: Elsevier; 2023.
  6. McPherson RA, Pincus MR, editores. Henry's clinical diagnosis and management by laboratory methods. 24th ed. St. Louis: Elsevier; 2021.
  7. Alberts B, Heald R, Johnson A, Morgan D, Raff M, Roberts K, et al. Molecular biology of the cell. 7th ed. Nueva York: W. W. Norton & Company; 2022.
  8. Krebs JE, Goldstein ES, Kilpatrick ST. Lewin's genes XII. Burlington (MA): Jones & Bartlett Learning; 2018.
  9. Cohn RD, Scherer SW, Hamosh A, editores. Thompson & Thompson genetics and genomics in medicine. 9th ed. Filadelfia: Elsevier; 2023.
  10. Gardner RJM, Amor DJ. Gardner and Sutherland's chromosome abnormalities and genetic counseling. 6th ed. Nueva York: Oxford University Press; 2025.
  11. Falconer DS, Mackay TFC. Introduction to quantitative genetics. 4th ed. Harlow: Longman; 1996.
Capítulo 1 · Biomoléculas, enzimas y bioenergética25

1.1–1.9 Proteínas, colágeno y hemoglobina

  1. Ricard-Blum S. The collagen family. Cold Spring Harb Perspect Biol. 2011;3(1):a004978. doi:doi.org
  2. Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, De Paepe A, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052. doi:doi.org
  3. Eunice Kennedy Shriver National Institute of Child Health and Human Development. What causes osteogenesis imperfecta? [Internet]. Bethesda: NIHnichd.nih.gov
  4. Manual MSD, versión para profesionales. Clinical types of Ehlers-Danlos syndromes [Internet]. Rahway (NJ): Merck & Co.msdmanuals.com
  5. Thom CS, Dickson CF, Gell DA, Weiss MJ. Hemoglobin variants: biochemical properties and clinical correlates. Cold Spring Harb Perspect Med. 2013;3(3):a011858.pmc.ncbi.nlm.nih.gov
  6. Morgan TJ. What is P50? [Internet]. Acute Care Testing; 2003acutecaretesting.org
  7. Berg JM, Tymoczko JL, Gatto GJ, Stryer L. Biochemistry. 8th ed. Nueva York: W. H. Freeman; 2015. Apéndice del capítulo 7 [Internet]digfir-published.macmillanusa.com
  8. University of California Santa Barbara, Biochemistry. The 2,3-BPG binding pocket of deoxyHb A [Internet]. Santa Bárbara: UCSBbiosci.mcdb.ucsb.edu
  9. University of California Santa Barbara, Biochemistry. Comparing the molecular structures of HbF and HbA [Internet]. Santa Bárbara: UCSBbiosci.mcdb.ucsb.edu
  10. Deranged Physiology. Transport of carbon dioxide in the blood [Internet]derangedphysiology.com

1.6–1.8 Glúcidos, lípidos y nucleótidos

  1. Barclay T, Ginic-Markovic M, Johnston MR, Cooper P, Petrovsky N. Observation of the keto tautomer of D-fructose in D2O using 1H NMR spectroscopy. Carbohydr Res. 2012;347(1):136-41. doi:doi.org
  2. OpenStax. Organic chemistry. 25.5 Cyclic structures of monosaccharides: anomers [Internet]. Houston: Rice Universityopenstax.org
  3. Dass AV, et al. Equilibrium and non-equilibrium furanose selection in the ribose isomerisation network [preprint]. arXiv:2010.13188arxiv.org
  4. Ji J, Sun L, Luo Z, Zhang Y, Wang X, Liao Y, et al. Potential therapeutic applications of pulmonary surfactant lipids in the host defence against respiratory viral infections. Front Immunol. 2021;12:730022. doi:doi.org

1.10–1.14 Enzimas, vitaminas, membranas y señalización

  1. Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Newsletter 2018: translocases (EC 7), a new EC class [Internet]. Londres: Queen Mary University of London; 2018iubmb.qmul.ac.uk
  2. Rhea. RHEA:80835: N-acylneuraminate-9-phosphate synthase (EC 2.5.1.57) [Internet]. Ginebra: SIB Swiss Institute of Bioinformaticsrhea-db.org
  3. Villaseca S, et al. Gαi protein subunit: a step toward understanding its non-canonical mechanisms. Front Cell Dev Biol. 2022;10:941870. doi:doi.org
  4. Encyclopedia MDPI. Entrada 26631: transportadores de glucosa GLUT [Internet]. Basilea: MDPIencyclopedia.pub

1.15–1.17 Bioenergética, cadena respiratoria y fosforilación oxidativa

  1. Watt IN, Montgomery MG, Runswick MJ, Leslie AGW, Walker JE. Bioenergetic cost of making an adenosine triphosphate molecule in animal mitochondria. Proc Natl Acad Sci U S A. 2010;107(39):16823-7. doi:doi.org
  2. RCSB Protein Data Bank. Entrada 2XND: ATP sintasa de mitocondria bovina [Internet]rcsb.org
  3. Hinkle PC. P/O ratios of mitochondrial oxidative phosphorylation. Biochim Biophys Acta. 2005;1706(1-2):1-11. Resumen en MitoFit [Internet]mitofit.org
  4. Blondin DP, et al. Human brown adipocyte thermogenesis is driven by β2-AR stimulation. Cell Metab. 2020;32(2):287-300. Nota de la Universidad de Copenhague [Internet]cbmr.ku.dk
  5. Koch J, et al. Inborn errors of the malate aspartate shuttle: update on patients and cellular models. Mol Genet Metab. 2024;142:108520boris.unibe.ch
  6. MitoPedia. Glutamate-aspartate carrier [Internet]mitophysiology.org
  7. DrugBank. SLC25A12 [Internet]go.drugbank.com

Fecha de consulta: 26 de octubre de 2026.

Capítulo 2 · Metabolismo48

2.1–2.6 Metabolismo de los glúcidos

  1. Galsgaard KD, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ. Glucagon receptor signaling and lipid metabolism. Front Physiol. 2019;10:413. doi:doi.org
  2. Kishnani PS, et al. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019;21(4):772-89. doi:doi.org
  3. Grünert SC, et al. Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. Orphanet J Rare Dis. 2020;15:218. doi:doi.org
  4. Agencia Europea de Medicamentos. Nexviadyme (avalglucosidasa alfa): EPAR [Internet]. Ámsterdam: EMA; 2022ema.europa.eu
  5. Amicus Therapeutics. EU approval of Opfolda (miglustat) with Pombiliti (cipaglucosidase alfa) for adults with late-onset Pompe disease [nota de prensa]. BioSpace; 27 jun 2023biospace.com
  6. Thalassaemia International Federation. Pyrukynd gets EU green light for pyruvate kinase deficiency [Internet]. 10 nov 2022thalassaemia.org.cy
  7. Agios. PYRUKYND (mitapivat) approved in the European Union for adults with thalassemia [nota de prensa]. BioSpace; 22 may 2026biospace.com
  8. Mayo Clinic Laboratories. Glucose-6-phosphate dehydrogenase genotyping: interpretive algorithm [Internet]. Rochester (MN): Mayo Clinicmayocliniclabs.com
  9. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency. Med J Aust. 2020;212(4):152-3mja.com.au
  10. Tang M, et al. Estimation of hereditary fructose intolerance prevalence in the Chinese population. Orphanet J Rare Dis. 2022;17:326. doi:doi.org
  11. De Vos A, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest. 1995;96(5):2489-95jci.org
  12. Atlas of Genetics and Cytogenetics in Oncology and Haematology. PFKFB2 [Internet]atlasgeneticsoncology.org
  13. Human Protein Atlas. GCGR (glucagon receptor) [Internet]proteinatlas.org

2.7–2.8 Piruvato deshidrogenasa y ciclo de Krebs

  1. BestBets. No evidence for administration of thiamine before glucose to the comatose patient [Internet]bestbets.org
  2. Agencia Europea de Medicamentos. Idhifa (enasidenib): retirada de la solicitud de autorización [Internet]. Ámsterdam: EMA; 6 dic 2019ema.europa.eu
  3. OncLive. Vorasidenib nets European approval in IDH1/2-mutated grade 2 glioma [Internet]. 22 sep 2025onclive.com

2.9–2.14 Metabolismo de los lípidos

  1. White H, Venkatesh B. Clinical review: ketones and brain injury. Crit Care. 2011;15(2):219. doi:doi.org
  2. Schönfeld P, Reiser G. Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab. 2013;33(10):1493-9. Resumen en Bioblast [Internet]bioblast.at
  3. Umpierrez GE, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024. Resumen en: Cleve Clin J Med. 2025;92(3):152ccjm.org
  4. Werner ER, Keller MA, Sailer S, et al. The TMEM189 gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens. Proc Natl Acad Sci U S A. 2020;117(14):7792-8pmc.ncbi.nlm.nih.gov
  5. Goldberg RB, Chait A. A comprehensive update on the chylomicronemia syndrome. Front Endocrinol (Lausanne). 2020;11:593931. doi:doi.org
  6. Di Taranto MD, Fortunato G. Genetic heterogeneity of familial hypercholesterolemia: repercussions for molecular diagnosis. Int J Mol Sci. 2023;24(4):3224. doi:doi.org
  7. European Society of Cardiology. 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias [Internet]. Sophia Antipolis: ESC; 2025escardio.org
  8. Agencia Europea de Medicamentos. Redemplo (plozasirán): EPAR [Internet]. Ámsterdam: EMA; 2026ema.europa.eu
  9. TCTMD. CLEAR Outcomes: CVD benefit with bempedoic acid [Internet]. 2023tctmd.com
  10. TCTMD. FDA approves enlicitide, an oral PCSK9 inhibitor [Internet]. 16 jul 2026tctmd.com
  11. HCPLive. Dyslipidemia in 2025: year in review [Internet]hcplive.com
  12. Zamel R, Khan R, Pollex RL, Hegele RA. Abetalipoproteinemia: two case reports and literature review. Orphanet J Rare Dis. 2008;3:19. doi:doi.org
  13. Junaid SZS, Patel K. Abetalipoproteinemia. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [actualizado 31 jul 2023].ncbi.nlm.nih.gov
  14. Burnett JR, Hooper AJ, Hegele RA. Abetalipoproteinemia. En: Adam MP, Feldman J, Mirzaa GM, et al., editores. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024 [actualizado 19 may 2022].ncbi.nlm.nih.gov
  15. Higuchi K, Hospattankar AV, Law SW, Meglin N, Cortright J, Brewer HB Jr. Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine. Proc Natl Acad Sci U S A. 1988;85(6):1772-6. doi:doi.org
  16. Blanc V, Davidson NO. Mouse and other rodent models of C to U RNA editing. Methods Mol Biol. 2011;718:121-35. doi:doi.org

2.15–2.19 Metabolismo del nitrógeno, aminoácidos, nucleótidos y hemo

  1. Agencia Europea de Medicamentos. Carbaglu (ácido carglúmico): EPAR [Internet]. Ámsterdam: EMAema.europa.eu
  2. Agencia Europea de Medicamentos. Sephience (sepiapterina): EPAR [Internet]. Ámsterdam: EMA; 2025ema.europa.eu
  3. National Center for Biotechnology Information. Medical genetics summaries: methylenetetrahydrofolate reductase deficiency [Internet]. Bethesda: NCBIncbi.nlm.nih.gov
  4. Patel P, Midha S, Shukla S, Dhamija D, Bello AO, Khan S. Evaluating the efficacy of a small interfering ribonucleic acid molecule, givosiran, in treating acute intermittent porphyria: a systematic review. Cureus. 2023;15(6):e40585. doi:doi.org
  5. Givlaari (givosirán): ficha técnica [Internet]. Electronic medicines compendiummedicines.org.uk
  6. National Organization for Rare Disorders. Porphyria [Internet]. Danbury (CT): NORDrarediseases.org
  7. Management of gout: update from the American College of Rheumatology (2020 guideline). Am Fam Physician. 2021aafp.org
  8. Das AM. Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1). Appl Clin Genet. 2017;10:43-8. doi:doi.org
  9. Elder AJ, Ali S. Nitisinone. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [actualizado 29 oct 2024].ncbi.nlm.nih.gov

2.20–2.23 Integración, errores congénitos y cribado neonatal

  1. Ferreira CR, Rahman S, Keller M, Zschocke J; ICIMD Advisory Group. An international classification of inherited metabolic disorders (ICIMD). J Inherit Metab Dis. 2021;44(1):164-77escholarship.org
  2. Cox TM. Gaucher disease: clinical profile and therapeutic developments. Biologics. 2010;4:299-313. doi:doi.org
  3. GeneCards. GBA1 gene (glucosylceramidase beta 1) [Internet]. Rehovot: Weizmann Institute of Sciencegenecards.org
  4. Ministerio de Sanidad. Programa de cribado neonatal de enfermedades congénitas en prueba de talón [Internet]. Madrid: Ministerio de Sanidad; 2026sanidad.gob.es
  5. Ministerio de Sanidad. El CISNS aprueba la inclusión de 10 nuevos cribados neonatales para enfermedades endocrino-metabólicas [nota de prensa]. Madrid; 12 nov 2025sanidad.gob.es
  6. Ley 3/2026, de 29 de julio, de modificación de normas sobre el programa de cribado neonatal del Sistema Nacional de Salud y de otra normativa. Boletín Oficial del Estado, n.º 186, de 31 de julio de 2026boe.es
  7. Farmaindustria. Informe sobre el cribado neonatal en las comunidades autónomas [Internet]. Madrid: Farmaindustria; feb 2026farmaindustria.es

Fecha de consulta: 26 de octubre de 2026.

Capítulo 3 · Bioquímica clínica59

3.1 Fase preanalítica e interferencias

  1. Acute Care Testing. Preanalytic error in plasma/serum glucose measurement examined [Internet]acutecaretesting.org
  2. Acute Care Testing. Arterial blood collection, part 1 of 2 [Internet]acutecaretesting.org
  3. University of Missouri School of Medicine. Ask a pathologist: biotin interference [Internet]. Columbia (MO)medicine.missouri.edu
  4. Association for Diagnostics & Laboratory Medicine (ADLM). How healthcare professionals can prevent biotin from interfering with medical tests [nota de prensa]. Ene 2020myadlm.org
  5. Doles N, Mon MY, Shaikh A, Mitchell S, Patel D, Seehusen D, et al. Interpreting normal values and reference ranges for laboratory tests. J Am Board Fam Med. 2025;38(1):174-9. doi:doi.org
  6. Timbrell NE. The role and limitations of the reference interval within clinical chemistry and its reliability for disease detection. Br J Biomed Sci. 2024;81:12339. doi:doi.org

3.2–3.4 Ácido-base, calcio, agua y función renal

  1. Acute Care Testing. Clinical aspects of the anion gap [Internet]acutecaretesting.org
  2. Manual MSD, versión para profesionales. Metabolic alkalosis [Internet]. Rahway (NJ): Merck & Co.msdmanuals.com
  3. Cavalier E, Zima T, Plebani M, et al. Albumin-adjusted (“corrected”) calcium should no longer be reported: a position statement from the Joint IOF Working Group and IFCC Committee on Bone Metabolism and EFLM Committee on CKD. Clin Chem Lab Med. 2026 [publicación anticipada]eflm.eu
  4. StatPearls. Familial hypocalciuric hypercalcemia [Internet]. Treasure Island (FL): StatPearls Publishingstatpearls.com
  5. Hormones Australia. Arginine vasopressin disorders (diabetes insipidus): fact sheet [Internet]. 2026hormones-australia.org.au
  6. The Royal Melbourne Hospital. Pathology handbook: copeptin [Internet]. Melbournethermh.org.au
  7. Manchester University NHS Foundation Trust. Arginine-stimulated copeptin test for diabetes insipidus (adults) [Internet]. Mánchester; 2023mft.nhs.uk
  8. Ampath. Ampath Chat 18.2: chronic kidney disease (CKD) update (resumen de la guía KDIGO 2024) [Internet]. Abr 2026ampath.co.za
  9. Šálek T, Stejskal D. Pseudonormokalemia case report: what does it mean to have normal blood potassium? Biochem Med (Zagreb). 2024;34(2):021002. doi:doi.org
  10. Roccaforte V, Alfreijat A. Spurious elevation of serum potassium concentration measured in samples with thrombocytosis. Diagnosis (Berl). 2016;3(3):125-8. doi:doi.org

3.5 Orina y líquidos biológicos

  1. Manual MSD, versión para profesionales. Análisis de semen (tabla basada en el WHO laboratory manual for the examination and processing of human semen, 6.ª ed., 2021) [Internet]. Rahway (NJ): Merck & Co.msdmanuals.com
  2. Boitrelle F, Shah R, Saleh R, Henkel R, Kandil H, Chung E, et al. The sixth edition of the WHO manual for human semen analysis: a critical review and SWOT analysis. Life (Basel). 2021;11(12):1368. doi:doi.org
  3. Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society guideline for pleural disease. Thorax. 2023;78(11):1143-56thorax.bmj.com
  4. Kopcinovic LM, Culej J. Pleural, peritoneal and pericardial effusions: a biochemical approach. Biochem Med (Zagreb). 2014;24(1):123-37. doi:doi.org
  5. Medmastery. Analyzing the cell count and protein concentration in ascites [Internet]medmastery.com
  6. Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician. 2005;71(6):1153-62.aafp.org
  7. Unić A, Nikolac Gabaj N, Miler M, Culej J, Lisac A, Horvat A, et al. Ascorbic acid—a black hole of urine chemistry screening. J Clin Lab Anal. 2018;32(5):e22390. doi:doi.org

3.6–3.8 Hígado, páncreas y corazón

  1. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-11. doi:doi.org
  2. European Association for the Study of the Liver, European Reference Network on Hepatological Diseases. EASL-ERN clinical practice guidelines on Wilson's disease. J Hepatol. 2025. doi: . Véase también:doi.orgemjreviews.com
  3. Manual MSD, versión para profesionales. Wilson disease [Internet]. Rahway (NJ): Merck & Co.msdmanuals.com
  4. Apple FS, Wu AHB, Sandoval Y, et al. Sex-specific 99th percentile upper reference limits for high sensitivity cardiac troponin assays derived using a universal sample bank. Clin Chem. 2020;66(3):434-44marketing.webassets.siemens-healthineers.com
  5. Ampath. Fast facts: the use of cardiac biomarkers in ACS, versión 2 [Internet]. Abr 2025ampath.co.za
  6. Implementación del algoritmo ESC 0 h/1 h [Internet]. Rev Esp Cardiol. 2023revespcardiol.org
  7. New developments in the investigations and diagnosis of heart failure [Internet]. Br J Cardiol. 2025bjcardio.co.uk
  8. [Puntos de corte de péptidos natriuréticos para el diagnóstico de insuficiencia cardiaca aguda y estable: tabla 1] [Internet]. PMC9791010pmc.ncbi.nlm.nih.gov
  9. AJMC. FDA clears first blood test for early detection of Alzheimer-linked amyloid plaques [Internet]. 19 may 2025ajmc.com

3.9–3.10 Glucosa y lípidos

  1. American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1)diabetesjournals.org
  2. CLP Magazine. Diabetes testing and the 2026 ADA Standards [Internet]clpmag.com
  3. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-46. doi: . Véase también:doi.orgcampus.sanofi
  4. MDCalc. SCORE2 (Systematic Coronary Risk Evaluation 2) [Internet]api.mdcalc.com
  5. TCTMD. Lp(a)HORIZON: top-line results dash hopes for pelacarsen [Internet]. Sep 2026tctmd.com
  6. Insights into the 2025 ESC focused update on dyslipidaemias [Internet]. Rev Esp Cardiol. 2025revespcardiol.org
  7. American College of Cardiology. 2019 ESC/EAS guidelines for the management of dyslipidaemias: ten points to remember [Internet]. 2019. Véase también: ESC Cardiopractice. Lipidology update: targets and timing of well-established therapies ;acc.orgescardio.org
  8. American College of Physicians. Diabetes Guide: consenso de 2024 sobre las crisis hiperglucémicas [Internet]. 12 jul 2024diabetesguide.acponline.org

3.11–3.14 Proteínas, hierro, metales, tóxicos y errores congénitos

  1. Organización Mundial de la Salud. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations [Internet]. Ginebra: OMS; 2020ncbi.nlm.nih.gov
  2. Iron deficiency anemia: guidelines from the American Gastroenterological Association [Internet]. Am Fam Physician. 2021aafp.org
  3. News-Medical. New iron deficiency guidelines raise key blood test cutoffs [Internet]. 9 oct 2026news-medical.net
  4. Instituto de Seguridad y Salud Laboral de la Región de Murcia. Ficha FTM-B-7: tolueno, o-cresol en orina [Internet]. Murciaissl.carm.es
  5. Ministerio de Sanidad. Programa de cribado neonatal de enfermedades congénitas en prueba de talón [Internet]. Madrid: Ministerio de Sanidad; 2026sanidad.gob.es
  6. Orden SND/356/2026, de 13 de abril (BOE de 20 de abril de 2026). Resumen en La Administración al Día [Internet]. Madrid: INAPlaadministracionaldia.inap.es
  7. Orden SND/454/2025, de 9 de mayo (BOE de 13 de mayo de 2025) [Internet] ;vlex.eslaadministracionaldia.inap.es
  8. Farmaindustria. Informe sobre el cribado neonatal en las comunidades autónomas [Internet]. Madrid: Farmaindustria; feb 2026farmaindustria.es
  9. Regina AC, Hai O. Cardiac glycoside and digoxin toxicity. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [actualizado 25 mar 2025].ncbi.nlm.nih.gov
  10. Williamson KM, Thrasher KA, Fulton KB, LaPointe NM, Dunham GD, Cooper AA, et al. Digoxin toxicity: an evaluation in current clinical practice. Arch Intern Med. 1998;158(22):2444-9. doi:doi.org
  11. Joshi PR, Deschauer M, Zierz S. McArdle disease: clinical, biochemical, histological and molecular genetic analysis of 60 patients. Biomedicines. 2020;8(2):33. doi:doi.org
  12. Martín MA, Lucia A, Arenas J, Andreu AL. Glycogen storage disease type V. En: Adam MP, Feldman J, Mirzaa GM, et al., editores. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024 [actualizado 20 jun 2019].ncbi.nlm.nih.gov
  13. Valen PA, Nakayama DA, Veum JA, Wortmann RL. Myoadenylate deaminase deficiency: diagnosis by forearm ischemic exercise testing and plasma purine measurements [resumen]. Pediatr Res. 1985;19(7):779. doi:doi.org
  14. Navarro-Fernández Balbuena C, Bonet-Arzo J, Esparza-Sánchez MA, Gormaz-Moreno M, Pantoja-Martínez J, Quintáns B. Déficit de mioadenilato desaminasa en un niño con mialgias inducidas por el ejercicio físico. Rev Neurol. 2004;39(5):431-4. doi:doi.org

3.15–3.18 Marcadores, hipófisis, tiroides, suprarrenal y gónadas

  1. Society of Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026 [Internet]. Mount Prospect (IL): SCCM; 2026 ;sccm.orgsccm.org
  2. Endocrine Society. Primary aldosteronism: clinical practice guideline 2025 [Internet]. Washington, DC: Endocrine Society; 2025endocrine.org
  3. Euronews. El País Vasco consigue reducir un 50 % la mortalidad por cáncer de colon con su programa de cribado [Internet]. 5 ago 2026es.euronews.com
  4. Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13-22. doi:doi.org
  5. Zeisler H, Llurba E, Chantraine FJ, et al. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Ultrasound Obstet Gynecol. 2019;53(3):367-75pmc.ncbi.nlm.nih.gov

Fecha de consulta: 26 de octubre de 2026.

Capítulo 4 · Biología molecular46

4.1–4.3 Ácidos nucleicos, cromatina y genoma

  1. Crick F. Central dogma of molecular biology. Nature. 1970;227:561-3. doi: . Véase también:doi.orgprofiles.nlm.nih.gov
  2. GENCODE. Human statistics, release 50 [Internet]. Hinxton: EMBL-EBI; 2026gencodegenes.org
  3. Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. The complete sequence of a human genome. Science. 2022;376(6588):44-53. doi: . Véase también:doi.orgpar.nsf.gov
  4. Rhie A, Nurk S, Cechova M, et al. The complete sequence of a human Y chromosome. Nature. 2023;621(7978):344-54. doi:doi.org
  5. Liao WW, Asri M, Ebler J, Doerr D, Haukness M, et al. A draft human pangenome reference. Nature. 2023;617(7960):312-24. doi:doi.org
  6. Fernández P, Amice R, Bruy D, Christenhusz MJM, Leitch IJ, Leitch AL, et al. A 160 Gbp fork fern genome shatters size record for eukaryotes. iScience. 2024;27(6):109889. doi: . Véase también:doi.orgkew.org
  7. Schartl M, Woltering JM, Irisarri I, Du K, Kneitz S, Pippel M, et al. The genomes of all lungfish inform on genome expansion and tetrapod evolution. Nature. 2024;634:96-103. doi: . Véase también:doi.orgsci.news
  8. Gregory TR. Animal genome size database [Internet]. 2026 ;genomesize.comgenomesize.com
  9. Sohn EJ, Goralsky JA, Shay JW, Min J. The molecular mechanisms and therapeutic prospects of alternative lengthening of telomeres (ALT). Cancers (Basel). 2023;15(7):1945. doi:doi.org
  10. Avery OT, MacLeod CM, McCarty M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med. 1944;79(2):137-58. doi:doi.org
  11. McCarty M, Avery OT. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. II. Effect of desoxyribonuclease on the biological activity of the transforming substance. J Exp Med. 1946;83(2):89-96. doi:doi.org
  12. Hayes W. The discovery of pneumococcal type transformation: an appreciation. J Hyg (Lond). 1966;64(2):177-84. doi:doi.org

4.4–4.6 Replicación, mutación, reparación y recombinación

  1. Burgers PMJ, Kunkel TA. Eukaryotic DNA replication fork. Annu Rev Biochem. 2017;86:417-38. doi:doi.org
  2. Smith DJ, Whitehouse I. Intrinsic coupling of lagging-strand synthesis to chromatin assembly. Nature. 2012;483:434-8. doi: . Véase también:doi.orgbionumbers.hms.harvard.edu
  3. Ward JF. DNA damage produced by ionizing radiation in mammalian cells. Prog Nucleic Acid Res Mol Biol. 1988;35:95-125. Citado en: University of Washington, Virtual Cell. DNA damage: background [Internet]faculty.washington.edu
  4. Markkanen E, Dorn J, Hübscher U. MUTYH DNA glycosylase: the rationale for removing undamaged bases from the DNA. Front Genet. 2013;4:18. doi:doi.org
  5. Kadyrov FA, Dzantiev L, Constantin N, Modrich P. Endonucleolytic function of MutLα in human mismatch repair. Cell. 2006;126(2):297-308. doi:doi.org
  6. Lujan SA, Williams JS, Clausen AR, Clark AB, Kunkel TA. Ribonucleotides are signals for mismatch repair of leading-strand replication errors. Mol Cell. 2013;50(3):437-43. doi:doi.org
  7. Weren RDA, Ligtenberg MJL, Kets CM, et al. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet. 2015;47(6):668-71. doi:doi.org
  8. den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564-9. doi:doi.org
  9. National Center for Biotechnology Information. ClinVar: NM_004004.6(GJB2):c.35del (p.Gly12fs) [Internet]. Bethesda: NLMncbi.nlm.nih.gov
  10. Meselson M, Stahl FW. The replication of DNA in Escherichia coli. Proc Natl Acad Sci U S A. 1958;44(7):671-82. doi:doi.org
  11. Sadava D, Hillis DM, Heller HC, Hacker SD. Life: the science of biology. 11th ed. Sunderland (MA): Sinauer/Macmillan; 2017. Cap. 13 (An elegant experiment demonstrated that DNA replication is semiconservative)digfir-published.macmillanusa.com

4.7–4.11 Transcripción, procesamiento, traducción y regulación

  1. Paget MS. Bacterial sigma factors and anti-sigma factors: structure, function and distribution. Biomolecules. 2015;5(3):1245-65. doi:doi.org
  2. Akinyi MV, Frilander MJ. At the intersection of major and minor spliceosomes: crosstalk mechanisms and their impact on gene expression. Front Genet. 2021;12:700744. doi:doi.org
  3. Grela P, Szajwaj M, Horbowicz-Drożdżal P, Tchórzewski M. How ricin damages the ribosome. Toxins (Basel). 2019;11(5):241. doi:doi.org
  4. MITOMAP. The human mitochondrial genetic code [Internet]mitomap.org
  5. Fromm B, Zhong X, Tarbier M, Friedländer MR, Hackenberg M. The limits of human microRNA annotation have been met. RNA. 2022;28(6):781-5. doi:doi.org
  6. ASBMB Today. 2024 Nobel Prize in Physiology or Medicine: Ambros and Ruvkun [Internet]. 7 oct 2024asbmb.org
  7. Agencia Europea de Medicamentos. Istodax (romidepsina): denegación de la autorización de comercialización [Internet]; y New treatment against Duchenne muscular dystrophy (givinostat), 25 abr 2025. Ámsterdam: EMA ;ema.europa.euema.europa.eu
  8. Jacob F, Perrin D, Sánchez C, Monod J. The operon: a group of genes with expression coordinated by an operator. C R Biol. 2005;328(6):514-20 (traducción de C R Acad Sci Paris. 1960;250:1727-9). doi:doi.org
  9. Pierce BA. Genetics essentials: concepts and connections. 3rd ed. Nueva York: W. H. Freeman/Macmillan; 2016. Cap. 12 (Mutations affecting the lac operon)digfir-published.macmillanusa.com

4.12 Técnicas, terapia génica y edición genómica

  1. Lundstrom K. Viral vectors in gene therapy: where do we stand in 2023? Viruses. 2023;15(3):698. doi:doi.org
  2. Zwi-Dantsis L, Mohamed S, Massaro G, Moeendarbary E. Adeno-associated virus vectors: principles, practices, and prospects in gene therapy. Viruses. 2025;17(2):239. doi:doi.org
  3. Marrone L, Marchi PM, Azzouz M. Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. Expert Opin Biol Ther. 2022;22(9):1163-76. doi:doi.org
  4. Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther. 2021;6(1):53. doi:doi.org
  5. Agencia Europea de Medicamentos. Casgevy (exagamglogén autotemcel): EPAR [Internet]. Ámsterdam: EMA; 2024ema.europa.eu
  6. Agencia Europea de Medicamentos. Hemgenix (etranacogén dezaparvovec): EPAR [Internet]. Ámsterdam: EMA; 2023ema.europa.eu
  7. Agencia Europea de Medicamentos. Upstaza (eladocagén exuparvovec): EPAR [Internet]. Ámsterdam: EMA; 2022ema.europa.eu
  8. Children's Hospital of Philadelphia. World's first patient treated with personalized CRISPR gene editing therapy [Internet]. 15 may 2025. Recoge: Musunuru K, et al. N Engl J Med. 2025 doi: . Véase también:doi.orgchop.edu
  9. CGTLive. Patient treated in Intellia transthyretin amyloidosis gene editing trial dies [Internet]. 9 nov 2025cgtlive.com
  10. AABB. FDA restricts CALD gene therapy after safety review [Internet]. 12 ago 2025aabb.org
  11. Wong ML, Medrano JF. Real-time PCR for mRNA quantitation. BioTechniques. 2005;39(1):75-85. doi:doi.org
  12. Kralik P, Ricchi M. A basic guide to real time PCR in microbial diagnostics: definitions, parameters, and everything. Front Microbiol. 2017;8:108. doi:doi.org
  13. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268(5218):1766-9. doi:doi.org
  14. Das AT, Tenenbaum L, Berkhout B. Tet-On systems for doxycycline-inducible gene expression. Curr Gene Ther. 2016;16(3):156-67. doi:doi.org

Fecha de consulta: 26 de octubre de 2026.

Capítulo 5 · Genética61

Normativa, cribado y medicamentos

  1. Orden SND/356/2026, de 13 de abril, por la que se modifican, en relación con la información y vigilancia en salud pública, cribados prenatales, neonatales y de cáncer colorrectal, los anexos I, II y III del Real Decreto 1030/2006. Boletín Oficial del Estado, n.º 96, de 20 de abril de 2026boe.es
  2. Ley 3/2026, de 29 de julio, de modificación de normas sobre el programa de cribado neonatal del Sistema Nacional de Salud y de otra normativa. Boletín Oficial del Estado, n.º 186, de 31 de julio de 2026boe.es
  3. Orden SND/454/2025, por la que se modifican los anexos I, II, III y VI del Real Decreto 1030/2006. Boletín Oficial del Estado, de 13 de mayo de 2025. Preámbulo [Internet]vlex.es
  4. INAP. La Administración al Día. Cartera de servicios comunes del Sistema Nacional de Salud (Orden SND/356/2026) [Internet]. 2026laadministracionaldia.inap.es
  5. Ministerio de Sanidad. Programa de cribado neonatal de enfermedades congénitas en prueba de talón [Internet]. Madrid: Ministerio de Sanidad; 2026sanidad.gob.es
  6. Ministerio de Sanidad. Cribado prenatal de anomalías cromosómicas: información general [Internet]. Madrid: Ministerio de Sanidad; 2024sanidad.gob.es
  7. Agencia Española de Medicamentos y Productos Sanitarios. Fluorouracilo, capecitabina, tegafur y flucitosina en pacientes con déficit de dihidropirimidina deshidrogenasa. Nota informativa MUH (FV) 8/2020 [Internet]. Madrid: AEMPS; 11 may 2020aemps.gob.es
  8. Junta de Castilla y León, Escuela de Pacientes. Día Nacional de la Fibrosis Quística [Internet]. Valladolidsaludcastillayleon.es
  9. Agencia Europea de Medicamentos. Elevidys (delandistrogén moxeparvovec): denegación de la autorización [Internet]. Ámsterdam: EMA; 2025ema.europa.eu
  10. Agencia Europea de Medicamentos. CHMP summary of positive opinion for Duvyzat (givinostat) [Internet]. Ámsterdam: EMA; 25 abr 2025ema.europa.eu
  11. Vertex Pharmaceuticals. European Commission approves Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) [nota de prensa]. BusinessWire; 26 jun 2025businesswire.com
  12. Cystic Fibrosis News Today. EMA panel recommends Kaftrio for wider range of CF-causing mutations [Internet]. 2025cysticfibrosisnewstoday.com
  13. Human Fertilisation and Embryology Authority. HFEA comments on the news that eight babies have been born after mitochondrial donation treatment [Internet]. Londres: HFEA; 16 jul 2025hfea.gov.uk

Nomenclatura, guías y clasificación de variantes

  1. Karger. ISCN 2024: an international system for human cytogenomic nomenclature [nota de prensa]. Basilea: Karger; 2024karger.com
  2. Hart RK, et al. HGVS nomenclature 2024: improvements to community engagement, usability, and computability. Genome Med. 2024. doi:doi.org
  3. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24. doi:doi.org
  4. Manickam K, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(11):2029-37. doi:doi.org
  5. Pejaver V, et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am J Hum Genet. 2022;109(12):2163-77. doi:doi.org
  6. ClinGen Sequence Variant Interpretation Working Group. Recommendation for the application of PM2 (PM2_Supporting) [Internet]. ClinGen CSpec Registryerepo.clinicalgenome.org
  7. Australasian Association of Clinical Geneticists. Final pilot for ACMG/AMP/CAP/ClinGen SVC v4: now open [Internet]. Jul 2026aacg.org.au
  8. American College of Medical Genetics and Genomics. ACMG releases 2025 update to secondary findings gene list (SF v3.3) [nota de prensa]. Bethesda: ACMG; 9 jul 2025acmg.net
  9. Frebourg T, et al.; European Reference Network GENTURIS. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum Genet. 2020;28(10):1379-86. doi:doi.org
  10. Plotkin SR, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med. 2022;24(9):1967-77. Resumen del UAB NF Program [Internet]uab.edu
  11. Human Genome Variation Society. HGVS Nomenclature: checklist for the description of sequence variants [Internet].hgvs-nomenclature.org
  12. EMQN CIC. Policy on variant nomenclature (DOC2702), v13 [Internet]. Manchester: EMQN; 2024.emqn.org

Cromosomopatías, síndromes y enfermedades monogénicas

  1. McDonald-McGinn DM, et al. 22q11.2 deletion syndrome. En: GeneReviews [Internet]. Seattle: University of Washington; 1999 [actualizado]ncbi.nlm.nih.gov
  2. Blagojevic C, et al. Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening. CMAJ Open. 2021;9(3):E802-9pubmed.ncbi.nlm.nih.gov
  3. Bidichandani SI, Delatycki MB. Friedreich ataxia. En: GeneReviews [Internet]. Seattle: University of Washington; 1998 [actualizado]ncbi.nlm.nih.gov
  4. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38(12):1249-63pmc.ncbi.nlm.nih.gov
  5. Madaan M, Mendez MD. Angelman syndrome. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishingncbi.nlm.nih.gov
  6. Falco M, Amabile S, Acquaviva F. RAI1 gene mutations: mechanisms of Smith-Magenis syndrome. Appl Clin Genet. 2017;10:85-94. doi:doi.org
  7. Online Mendelian Inheritance in Man. #118220 Charcot-Marie-Tooth disease, demyelinating, type 1A; *601097 PMP22 [Internet]. Baltimore: Johns Hopkins University ;omim.orgomim.org
  8. MedLink Neurology. Charcot-Marie-Tooth disease type 1A [Internet]medlink.com
  9. Mutton D, Alberman E, Hook EB. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. J Med Genet. 1996;33(5):387-94jmg.bmj.com
  10. Hochstenbach R, Poot M. Prevalence and phenotypic impact of Robertsonian translocations. Mol Syndromol. 2021;12(1):1-11. doi:doi.org
  11. Benke PJ. Down syndrome: risk and recurrence [Internet]. DS-Healthds-health.com
  12. GPnotebook. Maternal age and chance of Down's syndrome [Internet]gpnotebook.com
  13. ARUP Consult. Beckwith-Wiedemann and Russell-Silver syndromes [Internet]. Salt Lake City: ARUP Laboratoriesarupconsult.com
  14. Abbott Molecular. AneuVysion multicolor DNA probe kit [Internet]molecular.abbott
  15. Izhar R, et al. Fabry disease in women: genetic basis, available biomarkers, and clinical manifestations. Genes (Basel). 2024;15(1):37. doi:doi.org
  16. Lolli F, et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9-17. doi:doi.org
  17. Institut de Myologie. Improving assessment of the risk of DMD and BMD recurrence in the case of a de novo mutation [Internet]. Parísinstitut-myologie.org
  18. Chinnery PF, et al. Risk of developing a mitochondrial DNA deletion disorder. Lancet. 2004;364(9434):592-6
  19. University of Chicago Genetic Services. MECP2 (Rett syndrome) information sheet [Internet]. 2016dnatesting.uchicago.edu
  20. Mehta PA, Ebens C. Fanconi anemia. En: GeneReviews [Internet]. Seattle: University of Washington; 2002 [actualizado 2021]ern-ithaca.eu
  21. Langbehn DR, et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet. 2004;65(4):267-77
  22. Orphanet. Xeroderma pigmentosum [Internet] (ficha consultada a través de FindZebra)findzebra.com
  23. PathologyOutlines. Acute promyelocytic leukemia with PML::RARA [Internet]pathologyoutlines.com
  24. Neumomadrid. Monografía VIII: fibrosis quística. Antecedentes históricos y epidemiología [Internet]. Madridneumomadrid.org
  25. Sellier C, Usdin K, Pastori C, Peschansky VJ, Tassone F, Charlet-Berguerand N. The multiple molecular facets of fragile X-associated tremor/ataxia syndrome. J Neurodev Disord. 2014;6(1):23. doi:doi.org
  26. Kong HE, Zhao J, Xu S, Jin P, Jin Y. Fragile X-associated tremor/ataxia syndrome: from molecular pathogenesis to development of therapeutics. Front Cell Neurosci. 2017;11:128. doi:doi.org
  27. Sanders JR, Jones KT. Regulation of the meiotic divisions of mammalian oocytes and eggs. Biochem Soc Trans. 2018;46(4):797-806. doi:doi.org
  28. Kouznetsova A, Valentiniene S, Liu JG, Kitajima TS, Brismar H, Höög C. Aurora B and Aurora C pools at two chromosomal regions collaboratively maintain chromosome alignment and prevent aneuploidy at the second meiotic division in mammalian oocytes. Front Cell Dev Biol. 2024;12:1470981. doi:doi.org
  29. Miller DB, Piccolo SR. A survey of compound heterozygous variants in pediatric cancers and structural birth defects. Front Genet. 2021;12:640242. doi:doi.org
  30. GeneReviews® glossary. En: Adam MP, Feldman J, Mirzaa GM, et al., editores. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.ncbi.nlm.nih.gov

Ligamiento, genética de poblaciones, herencia multifactorial y riesgos

  1. Clerget-Darpoux F. Genetic linkage analysis. Atlas Genet Cytogenet Oncol Haematol. 2002atlasgeneticsoncology.org
  2. Bhérer C, Campbell CL, Auton A. Refined genetic maps reveal sexual dimorphism in human meiotic recombination at multiple scales. Nat Commun. 2017;8:14994. doi:doi.org
  3. Centers for Disease Control. Use of folic acid for prevention of spina bifida and other neural tube defects—1983-1991. MMWR Morb Mortal Wkly Rep. 1991;40(30):513-6cdc.gov
  4. Kuchenbaecker KB, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402-16. Resumen en The ASCO Post [Internet]ascopost.com
  5. De Meeûs T. Revisiting FIS, FST, Wahlund effects, and null alleles. J Hered. 2018;109(4):446-56. doi:doi.org
  6. Castric V, Bernatchez L, Belkhir K, Bonhomme F. Heterozygote deficiencies in small lacustrine populations of brook charr Salvelinus fontinalis Mitchill (Pisces, Salmonidae): a test of alternative hypotheses. Heredity. 2002;89(1):27-35. doi:doi.org

Fecha de consulta: 26 de octubre de 2026.

Fisiología

216 fuentes · 8 capítulos

Obras generales de referencia9
  1. Hall JE, Hall ME. Guyton y Hall. Tratado de fisiología médica. 14.ª ed. Barcelona: Elsevier; 2021.
  2. Boron WF, Boulpaep EL, editores. Medical physiology. 3rd ed. Filadelfia: Elsevier; 2017.
  3. Koeppen BM, Stanton BA, editores. Berne y Levy. Fisiología. 8.ª ed. Barcelona: Elsevier; 2024.
  4. Barrett KE, Brooks HL, Barman SM, Yuan JXJ. Ganong's review of medical physiology. 27th ed. Nueva York: McGraw Hill; 2025.
  5. Augustine GJ, Groh JM, Huettel SA, LaMantia AS, White LE, editores. Neuroscience. 7th ed. Nueva York: Oxford University Press; 2023.
  6. Kandel ER, Koester JD, Mack SH, Siegelbaum SA, editores. Principles of neural science. 6th ed. Nueva York: McGraw Hill; 2021.
  7. West JB, Luks AM. West. Fisiología respiratoria. Fundamentos. 11.ª ed. Barcelona: Wolters Kluwer; 2021.
  8. Koeppen BM, Stanton BA. Renal physiology. 6th ed. Filadelfia: Elsevier; 2019.
  9. Melmed S, Auchus RJ, Goldfine AB, Rosen CJ, Kopp PA, editores. Williams textbook of endocrinology. 15th ed. Filadelfia: Elsevier; 2024.
Capítulo 1 · Fisiología general, celular y muscular15

Guías, consensos y documentos oficiales

  1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi:doi.org
  2. Kirk B, Cawthon PM, Arai H, Ávila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024;53(3):afae052. doi: ;doi.orgdigital.library.adelaide.edu.au

Revisiones y artículos

  1. Stuart CA, Stone WL, Howell MEA, Brannon MF, Hall HK, Gibson AL, et al. Myosin content of individual human muscle fibers isolated by laser capture microdissection. Am J Physiol Cell Physiol. 2016;310(5):C381-9. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  2. Tobias A, Ballard BD, Mohiuddin SS. Physiology, water balance. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [actualizado 3 oct 2022].ncbi.nlm.nih.gov
  3. Beam KG, Bannister RA. Looking for answers to EC coupling's persistent questions. J Gen Physiol. 2010;136(1):7-12.rupress.org
  4. Woody MS, Winkelmann DA, Capitanio M, Ostap EM, Goldman YE. Single molecule mechanics resolves the earliest events in force generation by cardiac myosin. eLife. 2019;8:e49266. doi:doi.org
  5. Large MAF transcription factors reawaken type IIb myofibers in human skeletal muscle [preprint]. bioRxiv. 2024. doi:doi.org
  6. Dowling JJ, et al. STAC3 disorder. En: GeneReviews [Internet]. Seattle (WA): University of Washington; 2019.ncbi.nlm.nih.gov
  7. Malignant hyperthermia. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [actualizado 8 jun 2026].statpearls.com
  8. Blomqvist A, Engblom D. Neural mechanisms of inflammation-induced fever. Neuroscientist. 2018;24(4):381-99. doi:doi.org
  9. Lazarus M, Yoshida K, Coppari R, et al. EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses. Nat Neurosci. 2007;10(9):1131-3. doi:doi.org
  10. Brown adipose tissue and thermogenesis. Horm Mol Biol Clin Investig. 2014;19(1):25-37. doi:doi.org
  11. Blondin DP, Nielsen S, Kuipers EN, et al. Human brown adipocyte thermogenesis is driven by β2-AR stimulation. Cell Metab. 2020;32(2):287-300. Nota del Novo Nordisk Foundation Center for Basic Metabolic Research (Universidad de Copenhague), 4 ago 2020 [Internet]. doi: ;doi.orgcbmr.ku.dk

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Examine. What are the cut-off points for diagnosing sarcopenia? [Internet].examine.com
  2. Deranged Physiology. Relationship between muscle length and tension [Internet]. Resume Gordon AM, Huxley AF, Julian FJ. J Physiol. 1966;184(1):170-92.derangedphysiology.com
Capítulo 2 · Neurofisiología34

Guías, consensos y documentos oficiales

  1. The Nobel Assembly at Karolinska Institutet. The Nobel Prize in Physiology or Medicine 2021: press release [Internet]. Estocolmo: Nobel Prize Outreach; 2021.nobelprize.org
  2. European Medicines Agency. Quviviq (daridorexant): EPAR [Internet]. Ámsterdam: EMA.ema.europa.eu

Revisiones y artículos

  1. Lee P, Kim M, Szokol J, Bottros M. Suzetrigine: a novel, peripherally acting analgesic. APSF Newsletter [Internet]. 2025;40(2).apsf.org
  2. Touska F, et al. Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. J Gen Physiol. 2018.pmc.ncbi.nlm.nih.gov
  3. Chesler AT, et al. The role of PIEZO2 in human mechanosensation. N Engl J Med. 2016;375(14):1355-64. Resumen en BVS [Internet].pesquisa.bvsalud.org
  4. McKemy DD. How cold is it? TRPM8 and TRPA1 in the molecular logic of cold sensation. Mol Pain. 2005;1:16. doi:doi.org
  5. Schönfeld P, Reiser G. Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab. 2013;33(10):1493-9. doi: ;doi.orgbioblast.at
  6. Proulx ST. Cerebrospinal fluid outflow: a review of the historical and contemporary evidence for arachnoid villi, perineural routes, and dural lymphatics. Cell Mol Life Sci. 2021;78(6):2429-57. doi: ;doi.orgboris-portal.unibe.ch
  7. Steffensen AB, Oernbo EK, Stoica A, Gerkau NJ, Barbuskaite D, Tritsaris K, et al. Cotransporter-mediated water transport underlying cerebrospinal fluid formation. Nat Commun. 2018;9:2167. doi:doi.org
  8. Curcio CA, et al. Human photoreceptor topography. J Comp Neurol. 1990;292(4):497-523.pubmed.ncbi.nlm.nih.gov
  9. Leskov IB, et al. The gain of rod phototransduction: reconciliation of biochemical and electrophysiological measurements. Neuron. 2000;27(3):525-37.openresearch-repository.anu.edu.au
  10. Saszik S, DeVries SH. A mammalian retinal bipolar cell uses both graded changes in membrane voltage and all-or-nothing Na+ spikes to encode light. J Neurosci. 2012;32(1):297-307. doi:doi.org
  11. Pan B, Akyuz N, Liu XP, Asai Y, Nist-Lund C, Kurima K, et al. TMC1 forms the pore of mechanosensory transduction channels in vertebrate inner ear hair cells. Neuron. 2018;99(4):736-53.e6. doi:doi.org
  12. Jeong H, et al. Structures of the TMC-1 complex illuminate mechanosensory transduction. Nature. 2022;610(7933):796-803. doi: ;doi.orgideas.repec.org
  13. Ciganović N, Wolde-Kidan A, Reichenbach T. Hair bundles of cochlear outer hair cells are shaped to minimize their fluid-dynamic resistance. Sci Rep. 2017;7:3609. doi:doi.org
  14. Maresh A, Rodriguez Gil D, Whitman MC, Greer CA. Principles of glomerular organization in the human olfactory bulb: implications for odor processing. PLoS One. 2008;3(7):e2640. doi:doi.org
  15. Ma Z, Taruno A, Ohmoto M, Jyotaki M, Lim JC, Miyazaki H, et al. CALHM3 is essential for rapid ion channel-mediated purinergic neurotransmission of GPCR-mediated tastes. Neuron. 2018;98(3):547-61.e10. doi:doi.org
  16. Teng B, Wilson CE, Tu YH, Joshi NR, Kinnamon SC, Liman ER. Cellular and neural responses to sour stimuli require the proton channel Otop1. Curr Biol. 2019;29(21):3647-56.e5. doi:doi.org
  17. Kasahara Y, Narukawa M, Takeuchi A, et al. Molecular logic of salt taste reception in special reference to transmembrane channel-like 4 (TMC4). J Physiol Sci. 2022;72:31. doi:doi.org
  18. Kasahara Y, Narukawa M, Saito Y, Abe K, Asakura T. The complexities of salt taste reception: insights into the role of TMC4 in chloride taste detection. Front Mol Neurosci. 2024;17:1468438. doi:doi.org
  19. Perea-Martinez I, Nagai T, Chaudhari N. Functional cell types in taste buds have distinct longevities. PLoS One. 2013;8(1):e53399. doi:doi.org
  20. Voogd J. Deiters' nucleus. Cerebellum. 2016;15(1):1-24. doi:doi.org
  21. Nunzi MG, et al. Unipolar brush cells form a glutamatergic projection system within the mouse cerebellar cortex. J Comp Neurol. 2001;434(3):329-41. doi:doi.org
  22. Postuma RB, Iranzo A, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744-59.academic.oup.com

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Synapse (Patsnap). Suzetrigina: ficha del fármaco [Internet]. Actualizado 21 oct 2026.synapse.patsnap.com
  2. Clínica Universidad de Navarra. Diccionario médico: hemeralopía [Internet]. Pamplona: CUN.cun.es
  3. Open Exam Prep. Sleep architecture and stages: resumen de los estándares de la AASM [Internet].open-exam-prep.com
  4. Imperial College London. Scientists find sleep may not clear brain toxins [Internet]. Londres; 13 may 2024. Sobre: Miao A, Luo T, Hsieh B, et al. Brain clearance is reduced during sleep and anesthesia. Nat Neurosci. 2024. doi: ;doi.orgimperial.ac.uk
  5. Patient Care. FDA approves oveporexton, first orexin receptor agonist for narcolepsy type 1 [Internet]. 6 ago 2026.patientcareonline.com
  6. Monarch Initiative (DisMech). Narcolepsy-cataplexy syndrome [Internet].dismech.monarchinitiative.org
  7. Alzheimer's Disease International. European Commission approves first disease-modifying treatment for Alzheimer's disease in the EU [Internet]. Londres: ADI; 2025.alzint.org
  8. Eli Lilly and Company. Autorización del donanemab por la Comisión Europea [nota de prensa]. 25 sep 2025.investor.lilly.com
  9. Redacción Médica. Lecanemab y otros fármacos reciben un «no» de la CIPM [Internet]. 9 abr 2026.redaccionmedica.com
  10. El Español (Invertia). Rechazo a financiar un segundo fármaco para el alzhéimer [Internet]. 8 may 2026.elespanol.com
Capítulo 3 · Fisiología cardiovascular28

Guías, consensos y documentos oficiales

  1. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39. doi: ;doi.orgasecho.org
  2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi:doi.org
  3. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018. doi: ;doi.orgpace-cme.org
  4. Sociedad Española de Cardiología. Comentarios a la guía ESC 2024 sobre el manejo de la presión arterial elevada y la hipertensión. Rev Esp Cardiol. 2025.revespcardiol.org
  5. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874-2071. doi:doi.org
  6. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72. doi: ;doi.orgwfneurology.org
  7. Sheldon RS, Grubb BP 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-63. doi:doi.org
  8. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-731. doi: ;doi.orgacc.org

Revisiones y artículos

  1. Hennis K, Rötzer RD, Piantoni C, Biel M, Wahl-Schott C, Fenske S. Speeding up the heart? Traditional and new perspectives on HCN4 function. Front Physiol. 2021;12:669029. doi:doi.org
  2. Martinez ME, Walton RD, Bayer JD, Haïssaguerre M, Vigmond EJ, Hocini M, et al. Role of the Purkinje-muscle junction on the ventricular repolarization heterogeneity in the healthy and ischemic ovine ventricular myocardium. Front Physiol. 2018;9:718. doi:doi.org
  3. Seo K, Parikh VN, Ashley EA. Stretch-induced biased signaling in angiotensin II type 1 and apelin receptors for the mediation of cardiac contractility and hypertrophy. Front Physiol. 2020;11:181. doi:doi.org
  4. Cingolani HE, Pérez NG, Cingolani OH, Ennis IL. The Anrep effect: 100 years later. Am J Physiol Heart Circ Physiol. 2013;304(2):H175-82. doi:doi.org
  5. Meaney E, Alva F, Moguel R, Meaney A, Alva J, Webel R. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart. 2000;84(1):64. doi:doi.org
  6. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87(2):198-210. doi: ;doi.orgdbpia.nl.go.kr
  7. Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth. 2012;108(3):384-94. doi:doi.org
  8. Brassard P, Labrecque L, Smirl JD, Tymko MM, Caldwell HG, Hoiland RL, et al. Losing the dogmatic view of cerebral autoregulation. Physiol Rep. 2021;9(15):e14982. doi:doi.org
  9. Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009;32(7):533-6. doi:doi.org
  10. Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, et al. Endothelin. Pharmacol Rev. 2016;68(2):357-418. doi:doi.org
  11. Benditt DG, Fedorowski A, Sutton R, van Dijk JG, et al. Transient immediate orthostatic hypotension is preferable to initial orthostatic hypotension. Auton Neurosci. 2025;260:103288. doi: ;doi.orgpure.amsterdamumc.nl
  12. van Twist DJL, et al. Diagnostic criteria for initial orthostatic hypotension: a narrative review. Clin Auton Res. 2021;31(6):685-98.pure.amsterdamumc.nl
  13. Campagna JA, Carter C. Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology. 2003;98(5):1250-60. doi:doi.org
  14. Mark AL. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983;1(1):90-102. doi:doi.org

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Universidad de Sohag, Facultad de Medicina. Conduction system of the heart [Internet].med.sohag-univ.edu.eg
  2. Lecturio. Heart sounds [Internet].lecturio.com
  3. Marjot J. Vascular distensibility [Internet]. Sídney: South Eastern Sydney Local Health District.seslhd.health.nsw.gov.au
  4. The Blood Project. Fluid shifts after hemorrhage [Internet].thebloodproject.com
  5. Manual MSD, versión para profesionales. Classification of blood pressure in adults (AHA/ACC 2025) [Internet]. Rahway (NJ): Merck & Co.msdmanuals.com
  6. TeachMePhysiology. Fetal circulation [Internet].teachmephysiology.com
Capítulo 4 · Fisiología respiratoria25

Guías, consensos y documentos oficiales

  1. Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499. doi:doi.org
  2. Bhakta NR, Bime C, Kaminsky DA, et al. Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society statement. Am J Respir Crit Care Med. 2023;207(8):978-95. doi:doi.org
  3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). One blow is enough to exclude COPD [Internet]. 2024.goldcopd.org
  4. Luks AM, Beidleman BA, Freer L, Grissom CK, Keyes LE, McIntosh SE, et al. Wilderness Medical Society clinical practice guidelines for the prevention, diagnosis, and treatment of acute altitude illness: 2024 update. Wilderness Environ Med. 2024;35(1 Suppl):2S-19S. doi:doi.org
  5. Wilderness Medical Society. 2024 altitude summary [Internet].wms.org

Revisiones y artículos

  1. De Troyer A, Boriek AM. Mechanics of the respiratory muscles. Compr Physiol. 2011;1(3):1273-300. doi:doi.org
  2. Calculating the statistical limits of normal and Z-scores for pulmonary function tests. J Bras Pneumol. 2022.scielo.br
  3. Impact of 2022 ATS/ERS update criteria for bronchodilator response. Pulmonology. 2024.journalpulmonology.org
  4. Holm BA, Wang Z, Egan EA, Notter RH. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity. Pediatr Res. 1996;39(5):805-11. doi:doi.org
  5. Rehman S, Bacha D. Embryology, pulmonary. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.ncbi.nlm.nih.gov
  6. Durand F, Raberin A. Exercise-induced hypoxemia in endurance athletes: consequences for altitude exposure. Front Sports Act Living. 2021;3:663674. doi:doi.org
  7. Archer SL, Dunham-Snary KJ, Bentley RET, Alizadeh E, Weir EK. Hypoxic pulmonary vasoconstriction: an important component of the homeostatic oxygen sensing system. Physiol Res. 2024;73(Suppl 2):S493-510. doi: ;doi.orgbiomed.cas.cz
  8. Del Negro CA, Funk GD, Feldman JL. Breathing matters. Nat Rev Neurosci. 2018;19(6):351-67. doi: ;doi.orgescholarship.org
  9. Guyenet PG, Stornetta RL, Souza GMPR, Abbott SBG, Shi Y, Bayliss DA. The retrotrapezoid nucleus: central chemoreceptor and regulator of breathing automaticity. Trends Neurosci. 2019;42(11):807-24. doi:doi.org
  10. Guyenet PG, Bayliss DA. Proton detection and breathing regulation by the retrotrapezoid nucleus [resumen]. Proc Physiol Soc. 2016;37:SA083.physoc.org
  11. Bachmutsky I, Wei XP, Kish E, Yackle K. Opioids depress breathing through two small brainstem sites. eLife. 2020;9:e52694. doi:doi.org
  12. Holmes AP, Swiderska A, Nathanael D, Aldossary HS, Ray CJ, Coney AM, et al. Are multiple mitochondrial related signalling pathways involved in carotid body oxygen sensing? Front Physiol. 2022;13:908617. doi:doi.org
  13. Timón-Gómez A, et al. Tissue-specific mitochondrial HIGD1C promotes oxygen sensitivity in carotid body chemoreceptors. eLife. 2022;11:e78915. doi:doi.org
  14. Pamenter ME, Powell FL. Time domains of the hypoxic ventilatory response and their molecular basis. Compr Physiol. 2016;6(3):1345-85. doi:doi.org
  15. Haase VH. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev. 2013;27(1):41-53. doi:doi.org
  16. Moon RE. Decompression sickness. En: Manual MSD, versión para profesionales [Internet]. Rahway (NJ): Merck & Co.; [revisado jun 2025].msdmanuals.com
  17. Vann RD, Butler FK, Mitchell SJ, Moon RE. Decompression illness. Lancet. 2011;377(9760):153-64. doi:doi.org

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. MDedge. The latest on ERS/ATS lung function interpretation guidelines and bronchodilator testing [Internet].mdedge.com
  2. Respiratory Associates. An overview of the latest 2026 GOLD COPD guideline [Internet]. 2026.respiratoryassociates.com
  3. Divers Alert Network. Flying after diving [Internet]. 2021.dansa.org
Capítulo 5 · Fisiología renal30

Guías, consensos y documentos oficiales

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-314. doi: ;doi.orgajmc.com
  2. Cavalier E, et al.; EFLM Committee on Chronic Kidney Disease. Recommendations for European laboratories based on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD. Clin Chem Lab Med. 2025. doi:doi.org
  3. Arima H, Cheetham T, Christ-Crain M, et al. Changing the name of diabetes insipidus: a position statement of the Working Group for Renaming Diabetes Insipidus. J Clin Endocrinol Metab. 2023;108(1):1-3. doi:doi.org
  4. El-Hajj Fuleihan G, et al. Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023;108(3):507-28. doi: ;doi.orgendocrinenews.endocrine.org
  5. European Medicines Agency. Jesduvroq (daprodustat): retirada de la solicitud de autorización [Internet]. Ámsterdam: EMA.ema.europa.eu
  6. European Medicines Agency. Vafseo (vadadustat): EPAR [Internet]. Ámsterdam: EMA.ema.europa.eu

Revisiones y artículos

  1. Benzing T, Salant D. Insights into glomerular filtration and albuminuria. N Engl J Med. 2021;384(15):1437-46. doi: ;doi.orgbumc.bu.edu
  2. Comper WD. Commentary: the glomerular endothelium restricts albumin filtration. Front Med (Lausanne). 2022;9:861566. doi:doi.org
  3. Carlström M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev. 2015;95(2):405-511. doi:doi.org
  4. Allegaert K, Iacobelli S. Editorial: the developing kidney. Front Pediatr. 2022;10:990854. doi:doi.org
  5. Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-49. doi:doi.org
  6. Escribano-Serrano J, et al. ¿Es adecuado el uso de la nueva fórmula CKD-EPI 2021 en la población española? Rev Clin Esp. 2023;223(3):144-53.revclinesp.es
  7. Rieg T, Vallon V. Development of SGLT1 and SGLT2 inhibitors. Diabetologia. 2018;61(10):2079-86. doi:doi.org
  8. Kurtz I, Zhu Q. Proximal renal tubular acidosis mediated by mutations in NBCe1-A: unraveling the transporter's structure-functional properties. Front Physiol. 2013;4:350. doi:doi.org
  9. Sands JM, Layton HE. The physiology of urinary concentration: an update. Semin Nephrol. 2009;29(3):178-95. doi:doi.org
  10. Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. 2016;40(4):480-90. doi:doi.org
  11. Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015;10(7):1257-72. doi:doi.org
  12. Hamm LL, Nakhoul N, Hering-Smith KS. Acid-base homeostasis. Clin J Am Soc Nephrol. 2015;10(12):2232-42. doi:doi.org
  13. Adrogué HJ, Madias NE. Management of life-threatening acid-base disorders. Second of two parts. N Engl J Med. 1998;338(2):107-11. doi: ;doi.orgjacobimed.org
  14. Palmer BF, Alpern RJ. Metabolic alkalosis. J Am Soc Nephrol. 1997;8(9):1462-9.emcrit.org
  15. Ellison DH. Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol. 2019;14(8):1248-57. doi:doi.org
  16. Dhayat NA, et al. Hydrochlorothiazide and prevention of kidney-stone recurrence. N Engl J Med. 2023;388(9):781-91. Resumen en NephJC [Internet]. doi: ;doi.orgnephjc.com
  17. Souma T, Suzuki N, Yamamoto M. Renal erythropoietin-producing cells in health and disease. Front Physiol. 2015;6:167. doi:doi.org
  18. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453-66. doi:doi.org
  19. de Groat WC, Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol. 2015;5(1):327-96. doi:doi.org
  20. Estudio de imagen funcional de la micción voluntaria (circuito espinobulboespinal; centro pontino de la micción) [Internet]. PubMed Central: PMC4585491.pmc.ncbi.nlm.nih.gov
  21. Kleeman CR, Epstein FH, White C. The effect of variations in solute excretion and glomerular filtration on water diuresis. J Clin Invest. 1956;35(7):749-56. doi:doi.org
  22. Distenhreft JIQ, Vianna JGP, Scopel GS, Ramos JM, Seguro AC, Luchi WM. The role of urea-induced osmotic diuresis and hypernatremia in a critically ill patient: case report and literature review. J Bras Nefrol. 2020;42(1):106-12. doi:doi.org
  23. Lorenzo V. Doctor, how much should I drink? Nefrologia. 2014;34(6):693-7. doi:doi.org

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Bayer. Kerendia (finerenone) approved in EU for new indication in adult patients with heart failure with LVEF ≥ 40% [nota de prensa]. 30 mar 2026.bayer.com
Capítulo 6 · Fisiología de la sangre21

Guías, consensos y documentos oficiales

  1. Organización Mundial de la Salud. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. Ginebra: OMS; 2024. Resumen en: The Blood Project. Definition of anemia: Hb thresholds [Internet].thebloodproject.com
  2. International Society of Blood Transfusion (ISBT). ISBT announcement about the new PIGZ blood group system [Internet]. Ámsterdam: ISBT; 22 ago 2025.isbtweb.org
  3. Janssen-Cilag; Medsafe. Discontinuation of ReoPro (abciximab) [carta a profesionales sanitarios]. 1 abr 2020.medsafe.govt.nz
  4. Scottish Medicines Consortium. Tenecteplase (Metalyse): SMC2706 [Internet]. Glasgow: SMC; oct 2024.scottishmedicines.org.uk

Revisiones y artículos

  1. Kobayashi H, Liu Q, Binns TC, Urrutia AA, Davidoff O, Kapitsinou PP, et al. Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin. J Clin Invest. 2016;126(5):1926-38. doi:doi.org
  2. Mairbäurl H. Neocytolysis: how to get rid of the extra erythrocytes formed by stress erythropoiesis upon descent from high altitude. Front Physiol. 2018;9:345. doi:doi.org
  3. Reticulocyte count. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.ncbi.nlm.nih.gov
  4. Higgins C. Causes and clinical significance of increased carboxyhemoglobin [Internet]. Acutecaretesting.org; 2005.acutecaretesting.org
  5. Billesbølle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, Schneider S, et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature. 2020;586(7831):807-11. doi: ;doi.orgbiorxiv.org
  6. Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, et al. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood. 2018;131(8):899-910. doi:doi.org
  7. Rothenberger S, Iacopetta BJ, Kühn LC. Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site. Cell. 1987;49(3):423-31.infoscience.epfl.ch
  8. McGraw TE, Dunn KW, Maxfield FR. Phorbol ester treatment increases the exocytic rate of the transferrin receptor recycling pathway independent of serine-24 phosphorylation. J Cell Biol. 1988;106(4):1061-6.rupress.org
  9. Jing SQ, Spencer T, Miller K, Hopkins C, Trowbridge IS. Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization. J Cell Biol. 1990;110(2):283-94.rupress.org
  10. Lahoz-Beneytez J, Elemans M, Zhang Y, Ahmed R, Salam A, Block M, et al. Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives. Blood. 2016;127(26):3431-8.openaccess.sgul.ac.uk
  11. Sharda A, Flaumenhaft R. The life cycle of platelet granules. F1000Res. 2018;7:236.f1000research.com
  12. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958-65.scholars.duke.edu
  13. Munlemvo DM. The cell-based approach of hemostasis, coagulopathy, and the implications for the pediatric cardiac anesthesiologist. Front Anesthesiol. 2025;4:1454904. doi:doi.org
  14. Shamanaev A, Litvak M, Ivanov I, Srivastava P, Sun MF, Dickeson SK, et al. Factor XII structure-function relationships. Semin Thromb Hemost. 2024;50(7):937-52.pmc.ncbi.nlm.nih.gov
  15. Maas C, Renné T. Coagulation factor XII in thrombosis and inflammation. Blood. 2018;131(17):1903-9. doi:doi.org

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Bayer. Asundexian OCEANIC-STROKE phase III study results published in New England Journal of Medicine [nota de prensa]. 16 abr 2026.bayer.com
  2. AJMC. FDA approves garadacimab in hereditary angioedema [Internet]. 17 jun 2025.ajmc.com
Capítulo 7 · Fisiología endocrina y de la reproducción35

Guías, consensos y documentos oficiales

  1. American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1).diabetesjournals.org
  2. Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393-408. doi: ;doi.orgmsdmanuals.com
  3. Organización Mundial de la Salud. WHO laboratory manual for the examination and processing of human semen. 6th ed. Ginebra: OMS; 2021. Límites inferiores de referencia en: Manchester University NHS Foundation Trust. Lower reference limits 2021 [Internet].mft.nhs.uk
  4. Alpha Scientists in Reproductive Medicine; ESHRE Special Interest Group of Embryology. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Reprod Biomed Online. 2017;35(5):494-510. doi:doi.org
  5. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-89. doi:doi.org

Revisiones y artículos

  1. Richardson CC, Hussain K, Jones PM, Persaud S, Löbner K, Boehm A, et al. Low levels of glucose transporters and K+ATP channels in human pancreatic beta cells early in development. Diabetologia. 2007;50(5):1000-5. doi: ;doi.orgchannelpedia.epfl.ch
  2. Jennings RE, Berry AA, Strutt JP, Gerrard DT, Hanley NA. Human pancreas development. Development. 2015;142(18):3126-37. doi:doi.org
  3. Fichna M, Fichna P. Glucocorticoids and beta-cell function. Endokrynol Pol. 2017;68(5):568-73. doi:doi.org
  4. Baeyens L, Hindi S, Sorenson RL, German MS. β-Cell adaptation in pregnancy. Diabetes Obes Metab. 2016;18 Suppl 1:63-70. doi: ;doi.orgescholarship.org
  5. Refardt J, Atila C, Chifu I, et al. Arginine or hypertonic saline-stimulated copeptin to diagnose AVP deficiency. N Engl J Med. 2023;389(20):1877-87. doi: ; ;doi.org2minutemedicine.comendocrine-abstracts.org
  6. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest. 2005;115(9):2524-33. doi:doi.org
  7. Yakar S, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A. 1999;96(13):7324-9. doi:doi.org
  8. Rodríguez-Ortiz ME, Rodríguez M. FGF23 as a calciotropic hormone. F1000Res. 2015;4(F1000 Faculty Rev):1472. doi:doi.org
  9. Kalu DN, Hadji-Georgopoulos A, Foster GV. Evidence for physiological importance of calcitonin in the regulation of plasma calcium in rats. J Clin Invest. 1975;55(4):722-7. doi:doi.org
  10. Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, Lewis JG, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011;96(5):1533-40. doi:doi.org
  11. Lacroix MC, et al. Human placental growth hormone—a review. Placenta. 2002;23 Suppl A:S87-94. doi: ;doi.orgnutrition-evidence.com
  12. Kaiser UB. Hyperprolactinemia and infertility: new insights. J Clin Invest. 2012;122(10):3467-8. doi:doi.org
  13. Palumbo S, Cirillo G, Aiello F, Papparella A, Miraglia del Giudice E, Grandone A. MKRN3 role in regulating pubertal onset: the state of art of functional studies. Front Endocrinol (Lausanne). 2022;13:991322. doi:doi.org
  14. Josso N, Rey RA. What does AMH tell us in pediatric disorders of sex development? Front Endocrinol (Lausanne). 2020;11:619. doi:doi.org
  15. Amann RP. The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl. 2008;29(5):469-87. doi:doi.org
  16. Cornwall GA. New insights into epididymal biology and function. Hum Reprod Update. 2009;15(2):213-27. doi:doi.org
  17. Harakal J, Qiao H, Wheeler K, Rival C, Paul AGA, Hardy DM, et al. Exposed and sequestered antigens in testes and their protection by regulatory T cell-dependent systemic tolerance. Front Immunol. 2022;13:809247. doi:doi.org
  18. Baibakov B, et al. Human sperm bind to the N-terminal domain of ZP2 in humanized zonae pellucidae in transgenic mice. J Cell Biol. 2012;197(7):897-905.rupress.org
  19. Walkington L, Webster J, Hancock BW, Everard J, Coleman RE. Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease. Br J Cancer. 2011;104(11):1665-9. doi:doi.org
  20. Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, et al. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab. 1998;83(6):2175-85. doi:doi.org
  21. Rao D, Peitzsch M, Prejbisz A, Hanus K, Fassnacht M, Beuschlein F, et al. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma. Eur J Endocrinol. 2017;177(2):103-13. doi:doi.org
  22. Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816-25. doi:doi.org
  23. Ganesan K, Anastasopoulou C, Wadud K. Euthyroid sick syndrome. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [actualizado 8 dic 2022].ncbi.nlm.nih.gov

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Drucker DJ. The incretin effect [Internet]. Toronto: Lunenfeld-Tanenbaum Research Institute.glucagon.com
  2. Johns Hopkins Diabetes Guide. Prediabetes or categories of increased risk for diabetes [Internet].hopkinsguides.com
  3. Endocrine News. What's in a name? The move to rename diabetes insipidus gains momentum [Internet]. Washington, DC: Endocrine Society; nov 2022.endocrinenews.endocrine.org
  4. Quirónsalud. ¿A qué edad empieza la menopausia? [Internet].quironsalud.com
  5. University of California San Francisco. New findings on sperm life cycle could impact fertility treatments [nota de prensa]. 2006. Sobre: Misell LM, Holochwost D, Boban D, Santi N, Shefi S, Hellerstein MK, et al. A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo. J Urol. 2006;175(1):242-6.ucsf.edu
  6. Robaire Laboratory, McGill University. Table 8: epididymal transit time in different species [Internet]. Montreal: McGill University.mcgill.ca
  7. Manual MSD, versión para profesionales. Semen analysis [Internet]. Rahway (NJ): Merck & Co.msdmanuals.com
Capítulo 8 · Fisiología digestiva19

Revisiones y artículos

  1. Feldman M, Richardson CT, Taylor IL, Walsh JH. Effect of atropine on vagal release of gastrin and pancreatic polypeptide. J Clin Invest. 1979;63(2):294-8.jci.org
  2. Eysselein VE, Maxwell V, Reedy T, Wünsch E, Walsh JH. Similar acid stimulatory potencies of synthetic human big and little gastrins in man. J Clin Invest. 1984;74(5):1284-94.jci.org
  3. Engevik AC, Kaji I, Goldenring JR. The physiology of the gastric parietal cell. Physiol Rev. 2020;100(2):573-602.pmc.ncbi.nlm.nih.gov
  4. McLaughlin J, Grazia Lucà M, Jones MN, D'Amato M, Dockray GJ, Thompson DG. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. 1999;116(1):46-53.pubmed.ncbi.nlm.nih.gov
  5. Matzinger D, et al. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut. 2000;46(5):688-93.pmc.ncbi.nlm.nih.gov
  6. Takahashi T. Mechanism of interdigestive migrating motor complex. J Neurogastroenterol Motil. 2012;18(3):246-57. doi:doi.org
  7. Tack J, et al. Motilin-induced gastric contractions signal hunger in man. Gut. 2016;65(2):214-24.gut.bmj.com
  8. Zheng H, et al. Na+/Ca2+ exchange and pacemaker activity of interstitial cells of Cajal. Front Physiol. 2020;11:230. doi:doi.org
  9. Malone JC, Thavamani A. Physiology, gastrocolic reflex. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.ncbi.nlm.nih.gov
  10. Scheers I, Berardis S. Congenital etiologies of exocrine pancreatic insufficiency. Front Pediatr. 2022;10:909925. doi:doi.org
  11. Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009;50(12):2340-57.pmc.ncbi.nlm.nih.gov
  12. West AR, Oates PS. Mechanisms of heme iron absorption: current questions and controversies. World J Gastroenterol. 2008;14(26):4101-10.pmc.ncbi.nlm.nih.gov
  13. Elangovan R, Baruteau J. Inherited and acquired vitamin B12 deficiencies: which administration route to choose for supplementation? Front Pharmacol. 2022;13:972468. doi:doi.org
  14. Gautier-Stein A, Mithieux G. Intestinal gluconeogenesis: metabolic benefits make sense in the light of evolution. Nat Rev Gastroenterol Hepatol. 2023;20(3):183-94. doi:doi.org
  15. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:doi.org
  16. Do C, Vasquez PC, Soleimani M. Metabolic alkalosis pathogenesis, diagnosis, and treatment: core curriculum 2022. Am J Kidney Dis. 2022;80(4):536-51. doi:doi.org
  17. Alexandridis G, Elisaf M. Renal potassium handling in a patient with surreptitious vomiting [carta]. Nephrol Dial Transplant. 2001;16(11):2275. doi:doi.org

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. GPnotebook. Gallstones: epidemiology [Internet].gpnotebook.com
  2. UCSC Genome Browser. Lactase persistence [Internet]. Santa Cruz (CA): University of California Santa Cruz.genome.ucsc.edu

Fecha de consulta: 26 de octubre de 2026.

Infecciosas e Inmunología

375 fuentes · 7 capítulos

Obras generales de referencia9
  1. Murray PR, Rosenthal KS, Pfaller MA. Microbiología médica. 9.ª ed. Barcelona: Elsevier; 2021.
  2. Bennett JE, Dolin R, Blaser MJ, editores. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 9th ed. Filadelfia: Elsevier; 2020.
  3. Carroll KC, Pfaller MA, Karlowsky JA, Landry ML, McAdam AJ, Patel R, et al., editores. Manual of clinical microbiology. 13th ed. Washington, DC: ASM Press; 2023.
  4. Riedel S, Morse SA, Mietzner TA, Miller S. Jawetz, Melnick & Adelberg's medical microbiology. 28th ed. Nueva York: McGraw-Hill; 2019.
  5. Madigan MT, Bender KS, Buckley DH, Sattley WM, Stahl DA. Brock biology of microorganisms. 16th ed. Harlow: Pearson; 2021.
  6. Flint SJ, Racaniello VR, Rall GF, Hatziioannou T, Skalka AM. Principles of virology. 5th ed. Washington, DC: ASM Press; 2020.
  7. Abbas AK, Lichtman AH, Pillai S, Henrickson S. Cellular and molecular immunology. 11th ed. Filadelfia: Elsevier; 2025.
  8. Murphy K, Weaver C, Berg LJ. Janeway's immunobiology. 10th ed. Nueva York: W. W. Norton & Company; 2022.
  9. Farrar J, Garcia PJ, Hotez PJ, Junghanss T, Kang G, Lalloo DG, et al., editores. Manson's tropical diseases. 24th ed. Londres: Elsevier; 2023.
Capítulo 1 · Microbiología general25

Taxonomía y evolución

  1. Oren A, Garrity GM. Valid publication of the names of forty-two phyla of prokaryotes. Int J Syst Evol Microbiol. 2021;71(10):005056. doi:doi.org
  2. Göker M, Oren A. Valid publication of names of two domains and seven kingdoms of prokaryotes. Int J Syst Evol Microbiol. 2024;74(1):006242. doi:doi.org
  3. Eme L, Tamarit D, Caceres EF, Stairs CW, De Anda V, Schön ME, et al. Inference and reconstruction of the heimdallarchaeial ancestry of eukaryotes. Nature. 2023;618(7967):992-9. doi:doi.org
  4. Leibniz Institute DSMZ. LPSN – List of Prokaryotic names with Standing in Nomenclature [Internet]. Brunswick: DSMZ. Fichas de los reinos Bacillati y Pseudomonadati y de los filos Campylobacterota, Cyanobacteriota y Mycoplasmatota. ; ; ; ; ;lpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.de

Estructura, crecimiento y endospora

  1. Parker N, Schneegurt M, Tu AHT, Lister P, Forster BM. Microbiology [Internet]. Houston: OpenStax; 2016. Sección 9.4, Temperature and microbial growthopenstax.org
  2. Setlow P, Christie G. Bacterial spore mRNA – what's up with that? Front Microbiol. 2020;11:596092. doi:doi.org
  3. Liechti GW, Kuru E, Hall E, Kalinda A, Brun YV, VanNieuwenhze M, et al. A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis. Nature. 2014;506(7489):507-10. doi:doi.org

Microbiota y patogenicidad

  1. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:doi.org
  2. Lasica AM, Ksiazek M, Madej M, Potempa J. The type IX secretion system (T9SS): highlights and recent insights into its structure and function. Front Cell Infect Microbiol. 2017;7:215. doi:doi.org
  3. Organización Mundial de la Salud. Hepatitis C: nota descriptiva [Internet]. Ginebra: OMS; 2026who.int

Genética y resistencia

  1. Darby EM, Trampari E, Siasat P, Solsona Gaya M, Alav I, Webber MA, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21:280-95. doi:doi.org

Esterilización, desinfección y bioseguridad

  1. Centers for Disease Control and Prevention. Steam sterilization. En: Guideline for disinfection and sterilization in healthcare facilities, 2008 [Internet]. Atlanta: CDCcdc.gov
  2. Centers for Disease Control and Prevention. Resistance of microorganisms. En: Guideline for disinfection and sterilization in healthcare facilities, 2008 [Internet]. Atlanta: CDCcdc.gov
  3. Rutala WA. High-level disinfection, sterilization and antisepsis [diapositivas, Internet]. Chapel Hill: UNC SPICE; 2025spice.unc.edu
  4. Johnson E. Ensuring safe practices: managing surgical instruments in the context of Creutzfeldt-Jakob disease. Infection Control Today. 2025;29(1)infectioncontroltoday.com
  5. Real Decreto 664/1997, de 12 de mayo, sobre la protección de los trabajadores contra los riesgos relacionados con la exposición a agentes biológicos durante el trabajo. Boletín Oficial del Estado, n.º 124, de 24 de mayo de 1997 ;boe.essprl.upv.es
  6. Directiva (UE) 2020/739 de la Comisión, de 3 de junio de 2020, por la que se modifica el anexo III de la Directiva 2000/54/CE en lo que respecta a la inclusión del SARS-CoV-2 en la lista de agentes biológicos. Diario Oficial de la Unión Europea, L 175, de 4 de junio de 2020legislation.gov.uk
  7. Orden TES/1287/2021, por la que se adapta en función del progreso técnico el Real Decreto 664/1997 [reseña, Internet]. Laboral-Sociallaboral-social.com
  8. Instituto Nacional de Seguridad y Salud en el Trabajo. Jornada técnica: presentación de la actualización de la Guía técnica para la evaluación y prevención de los riesgos relacionados con la exposición a agentes biológicos durante el trabajo [Internet]. Madrid: INSSTinsst.es
  9. Organización Mundial de la Salud. Laboratory biosafety manual. 4th ed. Ginebra: OMS; 2020. Resumen de cambios: ABSA International [Internet]absa.org

Diagnóstico

  1. Oviaño M, Rodríguez-Sánchez B. MALDI-TOF mass spectrometry in the 21st century clinical microbiology laboratory. Enferm Infecc Microbiol Clin. 2021;39(4):192-200.elsevier.es
  2. European Committee on Antimicrobial Susceptibility Testing. EUCAST disk diffusion method for antimicrobial susceptibility testing, version 13.0 [Internet]. EUCAST; 2025eucast.org
  3. Kidd SE, Weldhagen GF. Diagnosis of dermatophytes: from microscopy to direct PCR. Microbiol Aust. 2022;43(1):9-13. doi:doi.org
  4. Pietzka A, Allerberger F, Murer A, Lennkh A, Stöger A, Cabal Rosel A, et al. Whole genome sequencing based surveillance of L. monocytogenes for early detection and investigations of listeriosis outbreaks. Front Public Health. 2019;7:139. doi:doi.org
  5. Organización Mundial de la Salud. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis [Internet]. Ginebra: OMS; 2024tbksp.who.int

Fecha de consulta: 25 y 26 de octubre de 2026.

Capítulo 2 · Bacteriología117

2.0–2.2 Envoltura bacteriana, estafilococos y estreptococos

  1. Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16:143-55. PMID: 29332945.
  2. Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals. J Antimicrob Chemother. 2021;76(10):2519-27.zaguan.unizar.es
  3. [Revisión sobre el SARM portador de mecC y su detección en el laboratorio]. PubMed Central; PMCID: PMC8210137pmc.ncbi.nlm.nih.gov
  4. [Bacteriemia por Staphylococcus aureus en España: SARM y resistencia a eritromicina en el SASM]. Front Microbiol. 2023;14:1220286. doi:doi.org
  5. [Staphylococcus saprophyticus en la infección urinaria]. PubMed Central; PMCID: PMC8645171pmc.ncbi.nlm.nih.gov
  6. Centers for Disease Control and Prevention. About staph food poisoning [Internet]. Atlanta: CDCcdc.gov
  7. Centers for Disease Control and Prevention, National Healthcare Safety Network. HAI pathogens and antimicrobial resistance, adult data 2018-2021: table 4 [Internet]. Atlanta: CDCcdc.gov
  8. European Centre for Disease Prevention and Control, Organización Mundial de la Salud (Oficina Regional para Europa). Antimicrobial resistance surveillance in Europe, 2023 data: executive summary [Internet]. Estocolmo: ECDCecdc.europa.eu
  9. European Centre for Disease Prevention and Control. Antimicrobial consumption and resistance: country sheet, Spain [Internet]. Estocolmo: ECDCantibiotic.ecdc.europa.eu
  10. Leibniz Institute DSMZ. LPSN – List of Prokaryotic names with Standing in Nomenclature [Internet]. Brunswick: DSMZ Fichas de Mammaliicoccus, Streptococcus gallolyticus subsp. gallolyticus y Streptococcus pasteurianus. ; ;lpsn.dsmz.delpsn.dsmz.delpsn.dsmz.de
  11. [Estudio nacional multicéntrico sobre Enterococcus: especies, resistencias intrínsecas y genes van]. Enferm Infecc Microbiol Clin. 2021.elsevier.es
  12. Centers for Disease Control and Prevention. Streptococcus laboratory: emm typing [Internet]. Atlanta: CDCcdc.gov
  13. Villalón P, et al. [Resistencia a macrólidos y sensibilidad a penicilina de Streptococcus pyogenes en España, 2007-2020]. Antibiotics (Basel). 2023;12(1):99. doi:doi.org
  14. [Revisión sobre la sensibilidad disminuida a betalactámicos en Streptococcus pyogenes]. Front Cell Infect Microbiol. 2023;13:1117160. doi:doi.org
  15. Ramírez de Arellano E, et al. [Estudio multicéntrico pediátrico español de infección invasiva por Streptococcus pyogenes]. mSphere. 2024. PMCID: PMC10964401.pmc.ncbi.nlm.nih.gov
  16. [Infección invasiva por Streptococcus pyogenes en el Hospital Universitario La Paz]. Enferm Infecc Microbiol Clin. 2023.elsevier.es
  17. Guía ABE. Infección perinatal por estreptococo del grupo B: profilaxis (v.2) [Internet]. 2022guia-abe.es
  18. Asociación Española de Vacunología. 20 años de vacunas antineumocócicas conjugadas: más de 100 serotipos de neumococo [Internet].vacunas.org
  19. [Descripción del serotipo neumocócico 33G]. PubMed Central; PMCID: PMC10782959ncbi.nlm.nih.gov
  20. Consejo Interterritorial del Sistema Nacional de Salud. Calendario común de vacunación e inmunización a lo largo de toda la vida 2026 [Internet]. Madrid: Ministerio de Sanidad; 2026saludcastillayleon.es
  21. Junta de Castilla y León, Consejería de Sanidad. Instrucción técnica de actualización del calendario de vacunaciones e inmunizaciones 2026 [Internet]. Valladolid; 2026saludcastillayleon.es
  22. Gobierno de Aragón, Dirección General de Salud Pública. Circular 02/2024: actualización de la vacunación frente al neumococo [Internet]. Zaragoza; 2024aragon.es
  23. Gobierno Vasco, Departamento de Salud. Nota informativa: vacunación frente al neumococo, septiembre de 2026 [Internet]. Vitoria-Gasteiz; 2026euskadi.eus
  24. Asociación Española de Pediatría. En Familia: vacuna del neumococo [Internet].enfamilia.aeped.es

2.3–2.4 Bacilos grampositivos

  1. Centers for Disease Control and Prevention. CDC guidelines for the prevention and treatment of anthrax, 2023. MMWR Recomm Rep. 2023;72(RR-6).cdc.gov
  2. Crobach MJT, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016.openaccess.sgul.ac.uk
  3. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023.cambridge.org
  4. [Comparación de las guías IDSA/SHEA y ESCMID de 2021 sobre la infección por Clostridioides difficile]. Antibiotics (Basel). 2022. PMCID: PMC9495463.pmc.ncbi.nlm.nih.gov
  5. Navigating recurrent Clostridioides difficile infection without bezlotoxumab: potential challenges ahead. Antimicrob Steward Healthc Epidemiol. 2025.cambridge.org
  6. Health Products Regulatory Authority. Zinplava: withdrawn medicines [Internet]. Dublín: HPRAhpra.ie
  7. Agencia Europea de Medicamentos. Zinplava (bezlotoxumab): EPAR [Internet]. Ámsterdam: EMAema.europa.eu
  8. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci U S A. 2003. PMCID: PMC298770.pmc.ncbi.nlm.nih.gov
  9. [Revisión de las principales toxinas de Bacillus cereus]. EXCLI J. 2026;25.excli.de
  10. [Revisión sobre Actinomyces y actinomicosis]. J Oral Microbiol. 2024. PMCID: PMC11100438.pmc.ncbi.nlm.nih.gov
  11. Leibniz Institute DSMZ. Cepa DSM 40040, Amycolatopsis orientalis [Internet]. Brunswick: DSMZdsmz.de
  12. Leibniz Institute DSMZ. LPSN – List of Prokaryotic names with Standing in Nomenclature [Internet]. Brunswick: DSMZ Fichas de Streptomyces erythraeus, Clostridioides, Clostridioides difficile, Cutibacterium y Gardnerella swidsinskii. ; ; ; ;lpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.de
  13. Centro Nacional de Epidemiología, ISCIII. Informe de listeriosis en España, 2023 (RENAVE) [Internet]. Madrid: ISCIIIcne.isciii.es
  14. Centro Nacional de Epidemiología, ISCIII. Tétanos en España, 1983-2023 [Internet]. Madrid: ISCIIIcne.isciii.es
  15. Centro Nacional de Epidemiología, ISCIII. Informe RENAVE de difteria, 2025 [Internet]. Madrid: ISCIIIcne.isciii.es
  16. Centers for Disease Control and Prevention. Bacterial vaginosis: STI treatment guidelines [Internet]. Atlanta: CDCcdc.gov
  17. Male-partner treatment to prevent recurrence of bacterial vaginosis (ensayo StepUp). N Engl J Med. 2025.
  18. Jean S, Lainhart W, Yarbrough ML. Closing the brief case: Erysipelothrix bacteremia and endocarditis in a 59-year-old immunocompromised male on chronic high-dose steroids. J Clin Microbiol. 2019;57(6):e02032-18. doi:doi.org
  19. Romney M, Cheung S, Montessori V. Erysipelothrix rhusiopathiae endocarditis and presumed osteomyelitis. Can J Infect Dis. 2001;12(4):254-6. doi:doi.org

2.5–2.6 Neisserias y enterobacterias

  1. Centro Nacional de Epidemiología, ISCIII. Enfermedad meningocócica invasiva en España, 2024. Boletín Epidemiológico Semanal [Internet]. Madrid: ISCIIIcne.isciii.es
  2. Ministerio de Sanidad. Enfermedad meningocócica invasiva: vacunación y grupos de riesgo [Internet]. Madridsanidad.gob.es
  3. Junta de Comunidades de Castilla-La Mancha, SESCAM. Documento técnico del calendario sistemático de vacunación 2026 [Internet]. Toledo; 2025sanidad.castillalamancha.es
  4. Junta de Andalucía. Instrucciones de vacunación frente a meningococo B y ACWY en Andalucía, 2026 [Internet]. Sevilla; 2026andavac.es
  5. Generalitat Valenciana. [Actualización del calendario de vacunación: MenACWY a los 4 y 12 meses] [Internet]. 2026coecs.com
  6. Servizo Galego de Saúde. Vacunación frente á gonorrea [Internet]. Santiago de Compostela: SERGAS; 2025sergas.gal
  7. Organización Mundial de la Salud. [Recomendaciones actualizadas para el tratamiento de la infección por Neisseria gonorrhoeae] [Internet]. Ginebra: OMS; 2024ncbi.nlm.nih.gov
  8. International Union against Sexually Transmitted Infections. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults [Internet]. IUSTI; 2020iusti.org
  9. European Centre for Disease Prevention and Control. STEC infection: annual epidemiological report for 2022 [Internet]. Estocolmo: ECDCecdc.europa.eu
  10. European Food Safety Authority, European Centre for Disease Prevention and Control. The European Union One Health 2024 zoonoses report [Internet]. Estocolmo: ECDCecdc.europa.eu
  11. [CARBA-MAP: distribución de carbapenemasas en España]. Front Microbiol. 2023;14:1247804. doi:doi.org
  12. [Carbapenemasas en enterobacterias]. Emerg Infect Dis. 2026;32(1).wwwnc.cdc.gov
  13. Leibniz Institute DSMZ. LPSN: familia Yersiniaceae [Internet]. Brunswick: DSMZlpsn.dsmz.de
  14. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021: gonococcal infections among neonates. MMWR Recomm Rep. 2021;70(4):1-187.cdc.gov
  15. Castro Ochoa KJ, Gurnani B. Ophthalmia neonatorum (neonatal conjunctivitis). En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [actualizado 7 jul 2025].ncbi.nlm.nih.gov

2.7–2.8 y 2.10 No fermentadores, Vibrio, Campylobacter, Helicobacter y anaerobios

  1. [VI Conferencia Española de Consenso sobre la infección por Helicobacter pylori]. Gastroenterol Hepatol. 2026.elsevier.es
  2. V Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterol Hepatol. 2022.elsevier.es
  3. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022. doi:doi.org
  4. [Tabla comparativa de las guías de tratamiento de Helicobacter pylori]. PubMed Central; PMCID: PMC10502504pmc.ncbi.nlm.nih.gov
  5. Infectious Diseases Society of America. IDSA 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections [Internet]. Arlington: IDSA; 2024idsociety.org
  6. [Comparación de las guías ESCMID 2022 e IDSA sobre gramnegativos multirresistentes]. PubMed Central; PMCID: PMC11201171pmc.ncbi.nlm.nih.gov
  7. Fratoni, et al. [Tratamiento de la infección por el complejo Burkholderia cepacia]. Clin Infect Dis. 2025;82(3):411.academic.oup.com
  8. [Tesis doctoral sobre clones de alto riesgo de Pseudomonas aeruginosa en España (dir. A. Oliver)]. Palma: Universitat de les Illes Balears; 2025.portalinvestigacio.uib.es
  9. Global Task Force on Cholera Control. Technical note: use of antibiotics for the treatment and control of cholera [Internet]. GTFCC; 2019gtfcc.org
  10. Organización Mundial de la Salud. Multi-country outbreak of cholera: external situation report n.º 32, 26 November 2025 [Internet]. Ginebra: OMS; 2025who.int
  11. Centers for Disease Control and Prevention. Health Alert Network: severe Vibrio vulnificus infections (HAN 00497) [Internet]. Atlanta: CDC; 2023cdc.gov
  12. European Centre for Disease Prevention and Control. Antimicrobial resistance in Campylobacter (annex C) [Internet]. Estocolmo: ECDCecdc.europa.eu
  13. Johannesen KM, Bodtger U. Lemierre's syndrome: current perspectives on diagnosis and management. Infect Drug Resist. 2016.dovepress.com
  14. [Resistencias de Bacteroides fragilis en hemocultivos de 16 países europeos]. Resumen del congreso DGHM-VAAM 2024 [Internet].programme.conventus.de
  15. [Tendencias de la sensibilidad antimicrobiana de las bacterias anaerobias en España]. Enferm Infecc Microbiol Clin.elsevier.es
  16. Leibniz Institute DSMZ. LPSN: Bacteroides vulgatus [Internet]. Brunswick: DSMZlpsn.dsmz.de

2.9 y 2.14 Bacilos gramnegativos pequeños e intracelulares obligados

  1. Preevid, Murcia Salud. [Semana recomendada para la vacunación de tos ferina en el embarazo] [Internet]. Murciamurciasalud.es
  2. [Brote de tos ferina en España, 2023-2024]. Gac Sanit. 2025.gacetasanitaria.org
  3. Centro Nacional de Epidemiología, ISCIII. Brote de tos ferina 2023-2024: informe de 23 de julio de 2024 [Internet]. Madrid: ISCIII; 2024cne.isciii.es
  4. Centro Nacional de Epidemiología, ISCIII. Brote de tos ferina 2023-2024: informe de 10 de diciembre de 2024 [Internet]. Madrid: ISCIII; 2024cne.isciii.es
  5. European Centre for Disease Prevention and Control. Pertussis: annual epidemiological report for 2024 [Internet]. Estocolmo: ECDCecdc.europa.eu
  6. [Resistencia a macrólidos en Bordetella pertussis en Francia, 2024]. Euro Surveill. 2024;29(31):2400459. doi:doi.org
  7. [Resistencia a macrólidos en Bordetella pertussis]. medRxiv [preprint]. 2025. doi:doi.org
  8. European Centre for Disease Prevention and Control. Legionnaires' disease: annual epidemiological report for 2024 [Internet]. Estocolmo: ECDCecdc.europa.eu
  9. Real Decreto 487/2022, de 21 de junio, por el que se establecen los requisitos sanitarios para la prevención y el control de la legionelosis. Boletín Oficial del Estado. 2022.boe.es
  10. [Tratamiento de la brucelosis humana]. Cochrane Database Syst Rev. 2022;CD007179.cochrane.org
  11. Centro Nacional de Epidemiología, ISCIII. Brucelosis: informe final 2022 [Internet]. Madrid: ISCIIIcne.isciii.es
  12. Centro Nacional de Epidemiología, ISCIII. Protocolo de vigilancia de tularemia [Internet]. Madrid: ISCIIIcne.isciii.es
  13. Junta de Andalucía, Consejería de Salud. Protocolo de tularemia [Internet]. Sevillajuntadeandalucia.es
  14. [Tularemia en España, 2015-2024]. Bol Epidemiol Semanal [Internet]. ISCIIIrevista.isciii.es
  15. Leibniz Institute DSMZ. LPSN: género Brucella [Internet]. Brunswick: DSMZlpsn.dsmz.de
  16. American Academy of Family Physicians. Choosing Wisely: Infectious Diseases Society of America [Internet]. AAFPaafp.org
  17. [Guías de tratamiento de las ITS de los CDC 2021: resumen para atención primaria]. Am Fam Physician. 2022.aafp.org
  18. Centro Nacional de Epidemiología, ISCIII. Vigilancia epidemiológica de las infecciones de transmisión sexual en España, 1995-2023 [Internet]. Madrid: ISCIIIcne.isciii.es
  19. Liechti GW, et al. A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis. Nature. 2013.
  20. Centers for Disease Control and Prevention. Clinical guidance for Q fever [Internet]. Atlanta: CDCcdc.gov
  21. Centro Nacional de Epidemiología, ISCIII. Informe RENAVE de fiebre exantemática mediterránea, 2024 [Internet]. Madrid: ISCIIIcne.isciii.es
  22. [Rickettsiosis asociada a linfangitis por Rickettsia sibirica mongolitimonae en España, 2007-2024]. Emerg Infect Dis. 2025;31(1).wwwnc.cdc.gov

2.11–2.13 Micobacterias, espiroquetas y micoplasmas

  1. Ministerio de Sanidad. Plan para la prevención y control de la tuberculosis en España, 2019: resumen [Internet]. Madrid; 2019mirror.mscbs.gob.es
  2. [Documento de consenso SEIMC/SEPAR sobre diagnóstico, tratamiento y prevención de la tuberculosis]. Arch Bronconeumol. 2010. ;archbronconeumol.orgseimc.org
  3. Preevid, Murcia Salud. [IGRA en personas vacunadas con BCG] [Internet]. Murciamurciasalud.es
  4. Asociación Española de Pediatría de Atención Primaria. [Tuberculosis en atención primaria]. Form Act Pediatr Aten Prim.fapap.es
  5. Agencia Española de Medicamentos y Productos Sanitarios. Ficha técnica de la tuberculina PPD [Internet]. Madrid: AEMPS, CIMAcima.aemps.es
  6. Organización Mundial de la Salud. WHO announces updated definitions of extensively drug-resistant tuberculosis [Internet]. Ginebra: OMS; 27 ene 2021who.int
  7. Centers for Disease Control and Prevention. Dear colleague letter: XDR TB surveillance definitions [Internet]. Atlanta: CDC; 2022archive.cdc.gov
  8. Organización Mundial de la Salud. TB Knowledge Sharing Platform: opciones de tratamiento de la tuberculosis sensible [Internet]. Ginebra: OMS ;tbksp.who.inttbksp.who.int
  9. Organización Mundial de la Salud. WHO announces landmark changes in treatment of drug-resistant tuberculosis [Internet]. Ginebra: OMS; 15 abr 2025who.int
  10. Organización Mundial de la Salud, Oficina Regional para Europa. Updated WHO recommendations and guidance on treatment of DR-TB [webinar, Internet]. Copenhague: OMS Europa; 2025vmc.euro.who.int
  11. Göker M, et al. [List of Recommended Names (LoRN) de bacterias de importancia médica]. Int J Syst Evol Microbiol. 2025;75:006943. PMCID: PMC12548757.pmc.ncbi.nlm.nih.gov
  12. Leibniz Institute DSMZ. LPSN – List of Prokaryotic names with Standing in Nomenclature [Internet]. Brunswick: DSMZ Fichas de Mycobacteroides abscessus, Borreliella burgdorferi, Mycoplasma, Mycoplasma pneumoniae, Mycoplasmoides genitalium y Metamycoplasma hominis. ; ; ; ; ;lpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.delpsn.dsmz.de
  13. International Committee on Systematics of Prokaryotes, Subcommittee on the Taxonomy of Mollicutes. FAQ (Opinion 122) [Internet].mollicutes.ipmb.sinica.edu.tw
  14. Edmondson DG, et al. Long-term in vitro culture of the syphilis spirochete Treponema pallidum subsp. pallidum. mBio. 2018. PMCID: PMC6020297.pmc.ncbi.nlm.nih.gov
  15. International Union against Sexually Transmitted Infections. 2020 European guideline on the management of syphilis [Internet]. IUSTI; 2020iusti.org
  16. Lantos PM, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021. PMCID: PMC8300839.pmc.ncbi.nlm.nih.gov
  17. Centers for Disease Control and Prevention. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep. 2019.stacks.cdc.gov
  18. Centro Nacional de Epidemiología, ISCIII. Informe RENAVE de fiebre recurrente transmitida por garrapatas, 2024 [Internet]. Madrid: ISCIIIinternacional.isciii.es
  19. [Fiebre recurrente transmitida por garrapatas por Borrelia hispanica]. Redalyc [Internet].redalyc.org
  20. Jensen JS, et al. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022.iusti.org
  21. [Resistencia a macrólidos y fluoroquinolonas en Mycoplasma genitalium en el Hospital Universitario La Paz, 2021]. Rev Esp Quimioter. 2023;36(3):310-3.seq.es

Fecha de consulta: 25 de octubre de 2026.

Capítulo 3 · Virología48

Taxonomía y nomenclatura

  1. Simmonds P, et al. Changes to virus taxonomy and the ICTV statutes ratified by the International Committee on Taxonomy of Viruses (2025). Arch Virol. 2026;171:23. doi:doi.org
  2. Zerbini FM, et al. Changes to virus taxonomy and the ICTV statutes ratified by the International Committee on Taxonomy of Viruses (2023). Arch Virol. 2023;168(7):175. doi:doi.org
  3. International Committee on Taxonomy of Viruses. ICTV Report on virus classification and taxon nomenclature [Internet]. Fichas de Alphaherpesvirinae, Flaviviridae, Sedoreoviridae, Kolmioviridae y Hepeviridae. ; ; ; ;ictv.globalictv.globalictv.globalictv.globalictv.global
  4. Mankertz A, Chen MH, Goldberg TL, Hübschen JM, Pfaff F, Ulrich RG; ICTV Report Consortium. ICTV virus taxonomy profile: Matonaviridae 2022. J Gen Virol. 2022;103(12):001817. doi:doi.org
  5. Bunyaviricetes [Internet]. DocCheck Flexikon [resumen de Kuhn JH, et al. J Virol. 2024]flexikon.doccheck.com
  6. [Nomenclatura binomial de las especies víricas: el VIH-1 pasa a Lentivirus humimdef1] [Internet]. POZpoz.com

Vacunas y sarampión

  1. Consejo Interterritorial del Sistema Nacional de Salud. Calendario común de vacunación e inmunización a lo largo de toda la vida 2026 [Internet]. Madrid: Ministerio de Sanidad; 2026saludcastillayleon.es
  2. Servicio Andaluz de Salud. Calendario de vacunaciones 2026 [Internet]. Sevilla; 2026andavac.es
  3. Gobierno de La Rioja. Protocolo de vacunación frente al virus del papiloma humano 2026 [Internet]. Logroño; 2026riojasalud.es
  4. Ministerio de Sanidad. Informe de situación del sarampión, 27 de enero de 2026 [Internet]. Madrid; 2026sanidad.gob.es
  5. Maldita.es. España pierde el distintivo de país libre de sarampión de la OMS [Internet]. 30 ene 2026maldita.es
  6. Prensa Latina. Seis países europeos pierden estatus de libres de sarampión [Internet]. 27 ene 2026prensa-latina.cu

Gripe, VRS y poliomielitis

  1. STAT News. FDA advisory panel recommends trivalent flu vaccines for 2024-2025 [Internet]. 5 mar 2024statnews.com
  2. European Centre for Disease Prevention and Control. Influenza virus characterisation: summary Europe, September 2024 [Internet]. Estocolmo: ECDC; 2024ecdc.europa.eu
  3. Organización Mundial de la Salud, Oficina Regional del Pacífico Occidental. Avian influenza weekly update, 25 September 2026 [Internet]. Manila: OMS; 2026cdn.who.int
  4. PHF Science. Overseas emerging respiratory virus intelligence, 6 August 2026 [Internet]. Nueva Zelanda; 2026phfscience.nz
  5. elDiario.es. Así evoluciona la expansión de la gripe aviar que ha obligado a confinar las granjas de aves en España [Internet]. 13 nov 2025eldiario.es
  6. [Propuesta de un nuevo subtipo de hemaglutinina, H19, en un ave silvestre de Kazajistán]. Front Vet Sci. 2023. doi:doi.org
  7. Servicio de Salud de Castilla-La Mancha. Documento técnico: inmunización frente al virus respiratorio sincitial con nirsevimab, temporada 2025-2026 [Internet]. Toledo: SESCAM; 2025sanidad.castillalamancha.es
  8. Organización Mundial de la Salud. Statement of the forty-third meeting of the Polio IHR Emergency Committee [Internet]. Ginebra: OMS; 11 nov 2025who.int
  9. Centers for Disease Control and Prevention. Notes from the field: detection of circulating vaccine-derived poliovirus type 2 in wastewater in Europe. MMWR Morb Mortal Wkly Rep. 2025;74(7)cdc.gov

Mpox

  1. Organización Mundial de la Salud. WHO Director-General's opening remarks at the IHR Emergency Committee regarding the upsurge of mpox 2024, 4 September 2025 [Internet]. Ginebra: OMS; 2025who.int
  2. Australian Associated Press. Mpox no longer an international health emergency: WHO [Internet]. 5 sep 2025katherinetimes.com.au
  3. Centro Nacional de Epidemiología, ISCIII. Situación epidemiológica de los casos de mpox en España, 4 de noviembre de 2025 [Internet]. Madrid: ISCIII; 2025cne.isciii.es
  4. Ministerio de Sanidad. Informe de situación: caso autóctono de mpox clado Ib, 16 de octubre de 2025 [Internet]. Madrid; 2025sanidad.gob.es
  5. European Centre for Disease Prevention and Control. Threat assessment brief: detection of autochthonous transmission of monkeypox virus clade Ib in the EU/EEA [Internet]. Estocolmo: ECDC; 24 oct 2025ecdc.europa.eu
  6. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Recomendaciones de vacunación frente a mpox [Internet]. Madrid: SEIMC; 2026seimc.org
  7. Agencia Europea de Medicamentos. EMA recommends extending indication of mpox vaccine to adolescents [Internet]. Ámsterdam: EMA; 19 sep 2024ema.europa.eu

Herpesvirus y parvovirus

  1. Contagion Live. FDA approves pritelivir for refractory HSV in immunocompromised adults [Internet]. 10 oct 2026. Véanse también las notas de MSKCC y Pharmazeutische Zeitung ; ;contagionlive.commskcc.orgpharmazeutische-zeitung.de
  2. Leruez-Ville M, et al. Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). Lancet Reg Health Eur. 2024doaj.org
  3. AMPATH. Fast facts: valacyclovir to prevent congenital CMV [Internet]. 2026ampath.co.za
  4. Agencia Española de Medicamentos y Productos Sanitarios. Brivudina (Nervinex y Brivudina Aristo): recordatorio de interacción potencialmente mortal con antineoplásicos que contienen 5-fluoropirimidinas. MUH(FV) 03/2023 [Internet]. Madrid: AEMPS; 2023aemps.gob.es
  5. Bieri J, Leisi R, Bircher C, Ros C. Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking. PLoS Pathog. 2021;17(4):e1009434. doi:doi.org
  6. European Centre for Disease Prevention and Control. Risks posed by reported increased circulation of human parvovirus B19 in the EU/EEA [Internet]. Estocolmo: ECDC; 5 jun 2024ecdc.europa.eu

VIH y hepatitis

  1. Gilead Sciences. European Commission authorizes twice-yearly Yeytuo (lenacapavir) for HIV prevention [Internet]. Business Wire; 25 ago 2025businesswire.com
  2. [Cohorte multicéntrica de TAR inicial con DTG/3TC o BIC/TAF/FTC en el diagnóstico tardío del VIH]. HIV Med. 2026;27(1):96-105. doi:doi.org
  3. GeSIDA-SEIMC. XV Congreso Nacional GeSIDA. Enferm Infecc Microbiol Clin. 2024;42(Supl 1)static.elsevier.es
  4. Contagion Live. HHS updates guidelines for antiretroviral treatment of HIV [Internet]. Sep 2026contagionlive.com
  5. American Gastroenterological Association. FDA approves first treatment for chronic HDV [Internet]. May 2026news.gastro.org
  6. Contagion Live. Bulevirtide approved as first US treatment for chronic hepatitis delta virus [Internet]. 22 may 2026contagionlive.com
  7. Duong N. Evidence-based GI: guía AASLD/IDSA 2025 sobre la hepatitis B [Internet]. American College of Gastroenterology; dic 2025mediacdn.gi.org
  8. Instituto de Salud Carlos III. Nota de prensa: estudio del ISCIII sobre las características de la hepatitis E en España (2009-2019) [Internet]. Madrid: ISCIII; 2022repisalud.isciii.es

Arbovirus y virus emergentes

  1. Amaro F, Zé-Zé L, Osório HC, Soares P, Silva M, Freitas IC, et al. Toscana virus in wild-caught sand flies in Portugal: findings from the national vector surveillance network, 2023. Pathogens. 2024;13(10):905. doi:doi.org
  2. Centro Nacional de Epidemiología, ISCIII. Informe epidemiológico RENAVE: fiebre del Nilo occidental en España, 2025 [Internet]. Madrid: ISCIII; 2026cne.isciii.es
  3. Centro Nacional de Epidemiología, ISCIII. Informe epidemiológico RENAVE: fiebre hemorrágica de Crimea-Congo en España, 2016-2024 [Internet]. Madrid: ISCIIIcne.isciii.es
  4. Ministerio de Sanidad. Mapa de casos de fiebre hemorrágica de Crimea-Congo en España, 2016-2026 [Internet]. Madrid; 13 ago 2026sanidad.gob.es
  5. Maldita.es. Dengue en España: riesgo bajo para la salud pública [Internet]. 9 may 2024maldita.es
  6. Europa Press. España notifica 124 casos importados de dengue y 108 de chikungunya en lo que va de año [Internet]. Periódico de Ibiza; 30 jul 2026periodicodeibiza.es

Fecha de consulta: 25 y 26 de octubre de 2026.

Capítulo 4 · Micología21

Levaduras: Candida, Candidozyma y criptococo

  1. Fernandes MAA, Aguiar FLL, Coutinho MGS, Brito EHS, Coelho CGV, Fontenelle ROS. Changes in nomenclature, virulence factors, and antifungal resistance of the genus Candida. Front Fungal Biol. 2025;6:1677892. doi:doi.org
  2. Liu F, Hu ZD, Zhao XM, et al. Phylogenomic analysis of the Candida auris–Candida haemulonii clade and related taxa in the Metschnikowiaceae, and proposal of thirteen new genera, fifty-five new combinations and nine new species. Persoonia. 2024;52:22-43. doi:doi.org
  3. Zhang SX, de Hoog S, Denning DW, et al. Reaffirming the importance of nomenclature stability for Candida auris and its associated disease of candidiasis. J Clin Microbiol. 2025;64(2):e01550-25. doi:doi.org
  4. Organización Mundial de la Salud. WHO fungal priority pathogens list to guide research, development and public health action [Internet]. Ginebra: OMS; 2022who.int
  5. European Centre for Disease Prevention and Control. Drug-resistant fungus Candidozyma auris confirmed to spread rapidly in European hospitals: ECDC calls for urgent action [Internet]. Estocolmo: ECDC; 11 sep 2025ecdc.europa.eu
  6. Rioja Salud. Evaluación de riesgo: Candidozyma auris [Internet]. Logroño: Gobierno de La Rioja; 2026riojasalud.es
  7. Science Media Centre España. Las infecciones por Candida auris en España son las más altas de Europa en la última década, según un informe del ECDC [Internet]. 11 sep 2025sciencemediacentre.es
  8. Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2025;25(5):e280-93. doi:doi.org
  9. Bender K. Global guideline on candidiasis, part II: treatments [Internet]. Contagion Live; 2025contagionlive.com
  10. Wilson J. Invasive candidiasis in 2026: harmonizing global and US guidance in an era of diagnostic and stewardship complexity [Internet]. Contagion Live; 22 ene 2026contagionlive.com
  11. Chang CC, Harrison TS, Bicanic TA, et al. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024;24(8):e495-512. doi:doi.org
  12. Organización Mundial de la Salud. Rapid advice: new guidelines for simpler, safer treatment for cryptococcal disease in people living with HIV [Internet]. Ginebra: OMS; 20 abr 2022who.int

Pneumocystis y hongos filamentosos

  1. Alanio A, Hauser PM, Lagrou K, et al. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2386-96. doi:doi.org
  2. Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother. 2016;71(9):2405-13. doi:doi.org
  3. Soto-Debrán JC, Sánchez-Íñigo FJ, Calvo-López AB, et al. High prevalence of azole resistance among environmental Aspergillus fumigatus isolates from outdoor air in Madrid, Spain. Front Microbiol. 2026;16:1722314. doi:doi.org
  4. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-21. doi:doi.org

Dermatofitos

  1. Abdolrasouli A, Barton RC, Borman AM, et al. Spread of antifungal-resistant Trichophyton indotineae, United Kingdom, 2017–2024. Emerg Infect Dis. 2025;31(1). doi:doi.org
  2. Castillo Gutiérrez M, Van Ingen Arteaga B. RF-Trichophyton indotineae: a new diagnostic and therapeutic challenge. Actas Dermosifiliogr. 2026;117(2):104516. doi:doi.org
  3. Comité de Medicamentos de la Asociación Española de Pediatría. Pediamécum: griseofulvina [Internet]. Madrid: AEPaeped.es

Microsporidios

  1. Centers for Disease Control and Prevention. DPDx: microsporidiosis [Internet]. Atlanta: CDCcdc.gov
  2. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Microsporidiosis [Internet]. ClinicalInfo HIV.govclinicalinfo.hiv.gov

Fecha de consulta: 25 y 26 de octubre de 2026.

Capítulo 5 · Parasitología51

Paludismo y babesiosis

  1. Organización Mundial de la Salud. WHO guidelines for malaria [Internet]. Ginebra: OMS; 30 nov 2024 (actualizada el 13 ago 2025) ;guidelinecentral.commesamalaria.org
  2. Organización Mundial de la Salud. World malaria report 2025 [Internet]. Ginebra: OMS; 2025who.int
  3. Organización Mundial de la Salud. Recomendación: primaquina en pauta de 7 días para la curación radical de P. vivax [Internet]. BIGG-recbigg-rec.bvsalud.org
  4. Organización Mundial de la Salud. Recomendación: tafenoquina para la curación radical de P. vivax [Internet]. BIGG-recbigg-rec.bvsalud.org
  5. GSK. First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO guidelines [Internet]. 4 dic 2024gsk.com
  6. Organización Mundial de la Salud. Safety of artemisinin and non-artemisinin antimalarials in the first trimester of pregnancy [Internet]. Ginebra: OMS; 2024who.int
  7. Swiss Tropical and Public Health Institute. Swissmedic approves first malaria treatment for newborns [Internet]. 8 jul 2025swisstph.ch
  8. Shaikh R, Ghosh K, Gorakshakar A. Plasmodium vivax infections in Duffy-negative individuals: a paradigm shift in Indian malaria epidemiology. Mediterr J Hematol Infect Dis. 2025;17(1):e2025044.mjhid.org
  9. Centro Nacional de Epidemiología, ISCIII. Informe epidemiológico sobre la situación del paludismo en España, año 2024 [Internet]. Madrid: ISCIIIcne.isciii.es
  10. Centers for Disease Control and Prevention. Clinical care of babesiosis [Internet]. Atlanta: CDCcdc.gov
  11. Centers for Disease Control and Prevention. DPDx: babesiosis [Internet]. Atlanta: CDCcdc.gov
  12. Centro de Coordinación de Alertas y Emergencias Sanitarias. Evaluación del riesgo de transmisión autóctona de paludismo en España [Internet]. Madrid: Ministerio de Sanidad; 2015sanidad.gob.es
  13. Centro Nacional de Epidemiología, ISCIII. Paludismo en España. Boletín Epidemiológico Semanal [Internet]revista.isciii.es

Protozoos intestinales y urogenitales

  1. Centers for Disease Control and Prevention. Treatment of cryptosporidiosis [Internet]. Atlanta: CDCcdc.gov
  2. Centro Nacional de Epidemiología, ISCIII. Informe epidemiológico sobre la situación de la criptosporidiosis en España, año 2024 [Internet]. Madrid: ISCIIIcne.isciii.es
  3. Centro Nacional de Epidemiología, ISCIII. Informe epidemiológico sobre la situación de la giardiosis en España, año 2024 [Internet]. Madrid: ISCIIIcne.isciii.es
  4. Ryan U, Paparini A, Monis P, Hijjawi N. It's official – Cryptosporidium is a gregarine: what are the implications for the water industry? Water Res. 2016;105:305-13.researchnow.flinders.edu.au
  5. Roche K, Dalle F, Capelli N, et al. From modern-day parasitology to paleoparasitology: the elusive past record and evolution of Cryptosporidium. Front Microbiol. 2023;14:1249884. doi:doi.org
  6. Centers for Disease Control and Prevention. DPDx: balantidiasis [Internet]. Atlanta: CDCcdc.gov
  7. Centers for Disease Control and Prevention. DPDx: Blastocystis [Internet]. Atlanta: CDCcdc.gov
  8. Centers for Disease Control and Prevention. DPDx: Dientamoeba fragilis [Internet]. Atlanta: CDCcdc.gov
  9. Menéndez C, Fernández-Suárez J, Boga Ribeiro JA, et al. Epidemiological and clinical characteristics of Dientamoeba fragilis infection. Enferm Infecc Microbiol Clin. 2019;37(5):290-5.elsevier.es
  10. Relias Media. CDC updates trichomoniasis treatment guidelines [Internet]reliasmedia.com

Amebas de vida libre

  1. Centers for Disease Control and Prevention. Clinical care of Naegleria fowleri infection [Internet]. Atlanta: CDCcdc.gov
  2. Centers for Disease Control and Prevention. Balamuthia amebic encephalitis — California, 1999-2007. MMWR Morb Mortal Wkly Rep. 2008;57(28):768-71cdc.gov
  3. Agencia Europea de Medicamentos. Akantior (polihexanida): EPAR [Internet]. Ámsterdam: EMA; 2024ema.europa.eu

Leishmania y tripanosomas

  1. Centro Nacional de Epidemiología, ISCIII. Informe epidemiológico sobre la situación de la leishmaniasis en España, año 2024 [Internet]. Madrid: ISCIIIcne.isciii.es
  2. Centro de Coordinación de Alertas y Emergencias Sanitarias. Leishmaniasis en España [Internet]. Madrid: Ministerio de Sanidad; 2012sanidad.gob.es
  3. Organización Mundial de la Salud. Visceral leishmaniasis and HIV coinfection: WHO publishes new guideline with region-specific treatment recommendations [Internet]. Ginebra: OMS; 8 jun 2022who.int
  4. Drugs for Neglected Diseases initiative. Sleeping sickness factsheet 2024 [Internet]. Ginebra: DNDi; 2025dndi.org
  5. Organización Mundial de la Salud. WHO interim guidelines for the treatment of gambiense human African trypanosomiasis [Internet]. Ginebra: OMS; 2019who.int
  6. Centers for Disease Control and Prevention. Clinical care of human African trypanosomiasis [Internet]. Atlanta: CDC; 2024cdc.gov
  7. Global Health EDCTP3. New single-dose oral treatment approved to fight sleeping sickness [Internet]. 18 mar 2026global-health-edctp3.europa.eu
  8. Francisco-González L, et al. Seroprevalence and vertical transmission of Chagas disease in a cohort of Latin-American pregnant women in a tertiary hospital in Madrid. An Pediatr (Barc). 2018.analesdepediatria.org
  9. Science Media Centre España. Reacción: la enfermedad de Chagas también está infradiagnosticada en España [Internet]sciencemediacentre.es
  10. ISGlobal. Más de 50 000 personas en España viven con Chagas y más del 70 % no están diagnosticadas ni tratadas [Internet]. Barcelona: ISGlobalisglobal.org
  11. American College of Cardiology. BENznidazole Evaluation For Interrupting Trypanosomiasis – BENEFIT [Internet] [resumen de Morillo CA, et al. N Engl J Med. 2015;373:1295-306]acc.org

Toxoplasma

  1. Fernández-Escobar M, et al. REIV-TOXO Project: results from a Spanish cohort of congenital toxoplasmosis (2015–2022). PLoS Negl Trop Dis. 2024doaj.org

Helmintos y artrópodos

  1. Organización Mundial de la Salud. WHO guidelines for the treatment of patients with cystic echinococcosis [Internet]. Ginebra: OMS; 2025who.int
  2. Centro Nacional de Epidemiología, ISCIII. Informe epidemiológico sobre la situación de la hidatidosis en España, año 2024 [Internet]. Madrid: ISCIIIcne.isciii.es
  3. White AC Jr, Coyle CM, Rajshekhar V, et al. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018;66(8):e49-75.pmc.ncbi.nlm.nih.gov
  4. Agencia Española de Seguridad Alimentaria y Nutrición. Anisakiasis [Internet]. Madrid: AESANaesan.gob.es
  5. Hopkins DR, et al. Progress toward global dracunculiasis (Guinea worm disease) eradication, January 2024–June 2025. MMWR Morb Mortal Wkly Rep. 2025;74(42)cdc.gov
  6. Dykie A, Wijesinghe T, Rabson AB, et al. HTLV-1 and Strongyloides stercoralis [Internet]. Encyclopedia MDPI [adaptado de Pathogens. 2020;9(11):904]encyclopedia.pub
  7. Organización Mundial de la Salud. Moxidectin approved by the Ghana Food and Drugs Authority: a new milestone in the fight against river blindness [Internet]. Ginebra: OMS; 12 dic 2024who.int
  8. Sanneh B, et al. Field evaluation of a schistosome circulating cathodic antigen rapid test kit at point-of-care for mapping of schistosomiasis endemic districts in The Gambia. PLoS One. 2017;12(8):e0182003. doi:doi.org
  9. Salas-Coronas J, Bargues MD, Lozano-Serrano AB, Artigas P, Martínez-Ortí A, Mas-Coma S, et al. Evidence of autochthonous transmission of urinary schistosomiasis in Almeria (southeast Spain): an outbreak analysis. Travel Med Infect Dis. 2021;44:102165. doi:doi.org
  10. Agencia Europea de Medicamentos. New treatment for young children with parasitic disease schistosomiasis [Internet]. Ámsterdam: EMA; dic 2023ema.europa.eu
  11. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Opisthorchis viverrini and Clonorchis sinensis. En: Biological agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 100B. Lyon: IARC; 2012ncbi.nlm.nih.gov
  12. The Carter Center. Guinea worm disease reaches all-time low: only 10 human cases reported in 2025 [Internet]. Atlanta; 30 ene 2026cartercenter.org
  13. CIDRAP. Guinea worm disease nears worldwide elimination, with only 10 cases in 2025 [Internet]. University of Minnesota; 2026cidrap.umn.edu

Fecha de consulta: 25 y 26 de octubre de 2026.

Capítulo 6 · Antiinfecciosos33

Sensibilidad y resistencia

  1. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints: breakpoints and guidance [Internet]. EUCAST; 2026eucast.org
  2. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 16.1 [Internet]. EUCAST; 2026eucast.org
  3. European Committee on Antimicrobial Susceptibility Testing. Expected resistant phenotypes, version 1.2 [Internet]. EUCAST; 2023eucast.org
  4. European Committee on Antimicrobial Susceptibility Testing. News [Internet]. EUCAST; 2026eucast.org
  5. Gracia-Ahufinger I, López-González L, Vasallo FJ, et al. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018). Front Microbiol. 2023;14:1247804. doi:doi.org
  6. CIDRAP. ECDC warns of rise in carbapenem-resistant Enterobacterales infections [Internet]. Minneapolis: University of Minnesota; 2025cidrap.umn.edu
  7. Contagion Live. IDSA 2024 guidance: key updates on managing antimicrobial-resistant gram-negative infections [Internet]. 2024contagionlive.com
  8. Harris PNA, Tambyah PA, Lye DC, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984-94. doi:doi.org

Antibacterianos nuevos y retirados

  1. Agencia Europea de Medicamentos. New antibiotic to fight infections caused by multidrug-resistant bacteria [Internet]. Ámsterdam: EMA; 22 mar 2024ema.europa.eu
  2. AbbVie. U.S. FDA approves Emblaveo (aztreonam and avibactam) [Internet]. 7 feb 2025news.abbvie.com
  3. Agencia Europea de Medicamentos. Exblifep (cefepima/enmetazobactam): EPAR [Internet]. Ámsterdam: EMA; 2024ema.europa.eu
  4. Pharmacy Times. FDA approves Xacduro for intravenous use in individuals with HAI Acinetobacter infections [Internet]. 25 may 2023pharmacytimes.com
  5. The Pharma Letter. FDA slaps CRL on cefepime-taniborbactam NDA [Internet]. 2024thepharmaletter.com
  6. Agencia Europea de Medicamentos. Vibativ (telavancina): withdrawal of the marketing authorisation in the European Union [Internet]. Ámsterdam: EMAema.europa.eu
  7. Healio. FDA approves first new gonorrhea treatment in decades [Internet]. 12 dic 2025healio.com
  8. GSK. Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urogenital gonorrhoea [Internet]. 11 dic 2025us.gsk.com
  9. European AIDS Treatment Group. FDA approves two oral therapies to treat gonorrhea [Internet]. Dic 2025eatg.org

Antituberculosos

  1. Centers for Disease Control and Prevention. Dear colleague letter: updated guidelines on the treatment of drug-susceptible and drug-resistant TB (ATS/CDC/ERS/IDSA) [Internet]. Atlanta: CDC; 2025cdc.gov
  2. Organización Mundial de la Salud. TB Knowledge Sharing Platform: 4-month regimen 2HPMZ/2HPM [Internet]. Ginebra: OMStbksp.who.int
  3. European AIDS Treatment Group. WHO announces landmark changes in treatment of drug-resistant TB [Internet]. 15 abr 2025eatg.org
  4. Mayo Clinic Center for Tuberculosis. Treatment guidelines [Internet]. Rochester: Mayo Cliniccenterfortuberculosis.mayo.edu
  5. Organización Mundial de la Salud. WHO announces updated definitions of extensively drug-resistant tuberculosis [Internet]. Ginebra: OMS; 27 ene 2021who.int

Antifúngicos

  1. Agencia Europea de Medicamentos. Rezzayo (rezafungina): EPAR [Internet]. Ámsterdam: EMA; 2023ema.europa.eu
  2. F2G, Shionogi. Positive topline results of the global phase 3 OASIS study evaluating oral olorofim [Internet]. BioNow; 18 jun 2026bionow.co.uk
  3. Basilea Pharmaceutica. Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis [Internet]. BioSpace; 2024biospace.com
  4. SCYNEXIS. Third quarter 2025 financial results and corporate update [Internet]. 2025ir.scynexis.com
  5. Fernandes MAA, Aguiar FLL, Coutinho MGS, Brito EHS, Coelho CGV, Fontenelle ROS. Changes in nomenclature, virulence factors, and antifungal resistance of the genus Candida. Front Fungal Biol. 2025;6:1677892. doi:doi.org

Antivirales

  1. Centers for Disease Control and Prevention. Influenza antiviral drug resistance [Internet]. Atlanta: CDCcdc.gov
  2. Agencia Europea de Medicamentos. Lagevrio (molnupiravir): withdrawn application [Internet]. Ámsterdam: EMA; 2023ema.europa.eu
  3. Gilead Sciences. European Commission authorizes twice-yearly Yeytuo (lenacapavir) for HIV prevention [Internet]. 26 ago 2025gilead.com
  4. European AIDS Clinical Society. EACS guidelines, version 13.0 [Internet]. Bruselas: EACS; 2025iris.unimo.it

Antiparasitarios

  1. Organización Mundial de la Salud. Artemisinin resistance: questions and answers [Internet]. Ginebra: OMSwho.int
  2. Global Health EDCTP3. EMA issues positive opinion on new treatment against sleeping sickness [Internet]. 27 feb 2026global-health-edctp3.europa.eu

Fecha de consulta: 25 de octubre de 2026.

Capítulo 7 · Inmunología71

7.1–7.5 Organización, células, órganos, inmunidad innata y complemento

  1. Helander HF, Fändriks L. Surface area of the digestive tract – revisited. Scand J Gastroenterol. 2014;49(6):681-9. Recogido en BioNumbers, ID 111126bionumbers.hms.harvard.edu
  2. Menny A, Serna M, Boyd CM, et al. CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. Nat Commun. 2018;9:5316.discovery.ucl.ac.uk
  3. Immunopaedia. Class switch recombination of antibodies occurs prior to germinal center formation [Internet] [comentario de Roco JA, et al. Immunity. 2019;51:337-50]immunopaedia.org.za
  4. GeneCards. GLYCAM1 gene [Internet]. Weizmann Institute of Sciencegenecards.org
  5. Weinstein AM, Storkus WJ. Biosynthesis and functional significance of peripheral node addressin in cancer-associated TLO. Front Immunol. 2016;7:301. doi:doi.org
  6. Barnum SR. C4a: an anaphylatoxin in name only. J Innate Immun. 2015;7(4):333-9.pmc.ncbi.nlm.nih.gov
  7. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol. 2004;138(3):439-46.core.ac.uk
  8. Saas P, Chagué C, Maraux M, Cherrier T. Toward the characterization of human pro-resolving macrophages? Front Immunol. 2020;11:593300. doi:doi.org
  9. Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization. Annu Rev Immunol. 2015;33:643-75. doi:doi.org
  10. Hellman L, Akula S, Fu Z, Wernersson S. Mast cell and basophil granule proteases – in vivo targets and function. Front Immunol. 2022;13:918305. doi:doi.org
  11. Rönnberg E, Boey DZH, Ravindran A, Säfholm J, Orre AC, Al-Ameri M, et al. Immunoprofiling reveals novel mast cell receptors and the continuous nature of human lung mast cell heterogeneity. Front Immunol. 2022;12:804812. doi:doi.org

Angioedema y fármacos frente al complemento

  1. Sobotkova M, Zachova R, Hakl R, Kuklinek P, Kralickova P, Krcmova I, et al. Acquired angioedema with C1 inhibitor deficiency: occurrence, clinical features, and management: a nationwide retrospective study in the Czech Republic patients. Int Arch Allergy Immunol. 2021;182(7):642-9. doi:doi.org
  2. The genetics of hereditary angioedema: a review. J Clin Med. 2021;10(9):2023. doi:doi.org
  3. University of Illinois Chicago, Drug Information Group. What new drugs are available for the management of hereditary angioedema? [Internet]. Chicago: UIC; oct 2025dig.pharmacy.uic.edu
  4. Agencia Europea de Medicamentos. Ekterly (sebetralstat): EPAR [Internet]. Ámsterdam: EMA; 2025ema.europa.eu
  5. Angioedema News. European regulators approve garadacimab as Andembry for HAE [Internet]. 17 feb 2025angioedemanews.com
  6. Ionis Pharmaceuticals. [Autorización de DAWNZERA (donidalorsen) por la Comisión Europea] [Internet]. Business Wire; 19 ene 2026businesswire.com
  7. European Academy of Allergy and Clinical Immunology. [Póster D3.55: variantes de DAB2IP en el angioedema hereditario con C1-INH normal]. EAACI Congress; 2024virtual.eaaci.org
  8. Agencia Europea de Medicamentos. Fabhalta (iptacopan): EPAR [Internet]. Ámsterdam: EMA; 2024ema.europa.eu
  9. Roche. PiaSky approved in the EU as the first monthly subcutaneous treatment for people with PNH [Internet]. Basilea: Roche; 27 ago 2024roche.com
  10. Medthority. Voydeya (danicopan) approved in the EU as add-on treatment to ravulizumab or eculizumab for adults with PNH who have residual haemolytic anaemia [Internet]. 23 abr 2024medthority.com
  11. Centers for Disease Control and Prevention. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep. 2017;66(27):734-7cdc.gov

7.6–7.13 Inmunidad adaptativa

  1. Recke A, Konitzer S, Lemcke S, et al. The p.Arg435His variation of IgG3 with high affinity to FcRn is associated with susceptibility for pemphigus vulgaris: analysis of four different ethnic cohorts. Front Immunol. 2018;9:1788. doi:doi.org
  2. Otsuka M, Egawa G, Kabashima K. Uncovering the mysteries of Langerhans cells, inflammatory dendritic epidermal cells, and monocyte-derived Langerhans cell-like cells in the epidermis. Front Immunol. 2018;9:1768. doi:doi.org
  3. IMGT, the international ImMunoGeneTics information system [Internet]. Montpellier: IMGT. Tablas de número de genes IG y TR humanos y de características de las cadenas de las inmunoglobulinas humanas ;imgt.orgimgt.org
  4. IPD-IMGT/HLA Database. HLA allele numbers [Internet]. 2024hla.alleles.org
  5. Liu X, Li Y, Wu W, et al. Regulatory mechanisms of Th9 cell differentiation. Front Immunol. 2025;16:1650972. doi:doi.org
  6. Helm EY, Zhou L. Transcriptional regulation of innate lymphoid cells and T cells by aryl hydrocarbon receptor. Front Immunol. 2023;14:1056267. doi:doi.org
  7. Organización Mundial de la Salud. New INN monoclonal antibody (mAb) nomenclature scheme. INN Working Doc. 22.542 [Internet]. Ginebra: OMS; 2022who.int
  8. Agencia Europea de Medicamentos. Imaavy (nipocalimab): EPAR [Internet]. Ámsterdam: EMA; 2025ema.europa.eu
  9. Agencia Europea de Medicamentos. Janus kinase inhibitors (JAKi): article 20 procedure. EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders [Internet]. Ámsterdam: EMA; 28 oct 2022ema.europa.eu
  10. Institute for Systems Biology. ISB's Dr. Mary Brunkow wins 2025 Nobel Prize in Physiology or Medicine [Internet]. Seattle: ISB; 2025isbscience.org
  11. Kimberlin DW, Stagno S. Can SARS-CoV-2 infection be acquired in utero? More definitive evidence is needed. JAMA. 2020;323(18):1788-9. doi:doi.org
  12. Ciobanu AM, Dumitru AE, Gica N, Botezatu R, Peltecu G, Panaitescu AM. Benefits and risks of IgG transplacental transfer. Diagnostics (Basel). 2020;10(8):583. doi:doi.org
  13. Xiong H, Dolpady J, Wabl M, Curotto de Lafaille MA, Lafaille JJ. Sequential class switching is required for the generation of high affinity IgE antibodies. J Exp Med. 2012;209(2):353-64. doi:doi.org
  14. Jabara HH, Loh R, Ramesh N, Vercelli D, Geha RS. Sequential switching from μ to ε via γ4 in human B cells stimulated with IL-4 and hydrocortisone. J Immunol. 1993;151(9):4528-33. PMID: 8409416.pubmed.ncbi.nlm.nih.gov
  15. Broggi A, Granucci F, Zanoni I. Type III interferons: balancing tissue tolerance and resistance to pathogen invasion. J Exp Med. 2020;217(1):e20190295. doi:doi.org
  16. Liu YG, Jin SW, Zhang SS, Xia TJ, Liao YH, Pan RL, et al. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium. Front Immunol. 2024;15:1338096. doi:doi.org

7.14–7.16 Hipersensibilidad, autoinmunidad e inmunodeficiencias

  1. Jutel M, Agache I, Zemelka-Wiacek M, et al. Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs. An EAACI position paper. Allergy. 2023;78(11):2851-74. doi:doi.org
  2. Endotypisierung 2.0 für Allergien. Dermatologie und Ästhetische Medizin. 2024;(4)rosenfluh.ch
  3. Valent P, Bonadonna P, Hartmann K, et al. Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome. Int Arch Allergy Immunol. 2019;180(1):44-51. doi:doi.org
  4. PathWest Laboratory Medicine WA. Sampling time recommendations for mast cell tryptase [Internet]. Perth; 22 dic 2023pathwest.health.wa.gov.au
  5. Bossuyt X, Cohen Tervaert JW, Arimura Y, et al. Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13:683-92. doi:doi.org
  6. University of Oxford. Autoimmune disorders found to affect around one in ten people [Internet] [sobre Conrad N, et al. Lancet. 2023;401:1878-90]. 6 may 2023ox.ac.uk
  7. CSL Vifor. European Commission adopts decision to revoke marketing authorisation for TAVNEOS (avacopan) in the European Union and European Economic Area countries [Internet]. 6 ago 2026newsroom.csl.com
  8. Poli MC, et al. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. J Hum Immun. 2025;1(1):e20250003. doi:doi.org
  9. Procurador del Común de Castilla y León. Resolución sobre el cribado neonatal (Orden SAN/957/2025) [Internet]. León; 2026procuradordelcomun.org
  10. Ministerio de Sanidad. Cribado neonatal: inmunodeficiencia combinada grave [Internet]. Madrid; 2025sanidad.gob.es
  11. Ministerio de Sanidad. Nota de prensa sobre la ampliación del cribado neonatal [Internet]. Madrid; 16 abr 2024sanidad.gob.es
  12. Hsu AP, Davis J, Puck JM, Holland SM, Freeman AF. STAT3 hyper IgE syndrome. En: GeneReviews [Internet]. Seattle: University of Washington; 1993–pubmed.ncbi.nlm.nih.gov
  13. Freeman AF, Holland SM. The hyper-IgE syndromes. Immunol Allergy Clin North Am. 2008;28(2):277-91pmc.ncbi.nlm.nih.gov
  14. Immune Deficiency Foundation. Hyper IgE syndromes [Internet]primaryimmune.org
  15. Veenhuis S, van Os N, Weemaes C, et al. Ataxia-telangiectasia. En: GeneReviews [Internet]. Seattle: University of Washingtonncbi.nlm.nih.gov
  16. Rothblum-Oviatt C, Wright J, Lefton-Greif MA, et al. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:159ojrd.biomedcentral.com
  17. Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014;26(6):454-70pmc.ncbi.nlm.nih.gov
  18. Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet. 2020;139:993-1000pmc.ncbi.nlm.nih.gov

7.17–7.21 Trasplante, inmunología tumoral, vacunas y técnicas

  1. Agencia Europea de Medicamentos. New medicine to treat chronic graft-versus-host disease [Internet]. Ámsterdam: EMA; 30 ene 2026ema.europa.eu
  2. Sanofi. Rezurock approved in the EU to treat chronic graft-vs-host disease [Internet]. BioSpace; 2026biospace.com
  3. Agencia Europea de Medicamentos. Aucatzyl (obecabtagén autoleucel): EPAR [Internet]. Ámsterdam: EMA; 2025ema.europa.eu
  4. U.S. Food and Drug Administration. FDA eliminates Risk Evaluation and Mitigation Strategies (REMS) for autologous chimeric antigen receptor CAR T cell immunotherapies [Internet]. Silver Spring: FDA; 26 jun 2025fda.gov
  5. Agencia Europea de Medicamentos. Amtagvi (lifileucel): solicitud retirada [Internet]. Ámsterdam: EMA; 2025ema.europa.eu
  6. Agencia Europea de Medicamentos. Opdualag (nivolumab/relatlimab): EPAR [Internet]. Ámsterdam: EMA; 2022ema.europa.eu
  7. Agencia Europea de Medicamentos. Imdylltra (tarlatamab): EPAR [Internet]. Ámsterdam: EMA; 2026ema.europa.eu
  8. Consejo Interterritorial del Sistema Nacional de Salud. Calendario común de vacunación e inmunización a lo largo de toda la vida: calendario recomendado año 2026 [Internet]. Madrid: Ministerio de Sanidad; 2025sanidad.gob.es
  9. Servicio de Salud de Castilla-La Mancha. Documento técnico: calendario de vacunación sistemático 2026 [Internet]. Toledo: SESCAM; 2025sanidad.castillalamancha.es
  10. Gobierno Vasco, Departamento de Salud. Calendario vacunal infantil de 2026 [Internet]. Vitoria-Gasteiz; 2026euskadi.eus
  11. Diario de León. Castilla y León publica el calendario de vacunación de 2026 [Internet]. 6 mar 2026diariodeleon.es
  12. Agencia Europea de Medicamentos. Enflonsia (clesrovimab): EPAR [Internet]. Ámsterdam: EMA; 2026ema.europa.eu
  13. ATCC. Hep-2 [HEp-2] (CCL-23) [Internet]. Manassas: ATCCatcc.org
  14. Zhang W, Huang Q, Xiao W, Zhao Y, Pi J, Xu H, et al. Advances in anti-tumor treatments targeting the CD47/SIRPα axis. Front Immunol. 2020;11:18. doi:doi.org
  15. Jia X, Yan B, Tian X, Liu Q, Jin J, Shi J, et al. CD47/SIRPα pathway mediates cancer immune escape and immunotherapy. Int J Biol Sci. 2021;17(13):3281-7. doi:doi.org

Fecha de consulta: 25 y 26 de octubre de 2026.

Citología, Histología y Embriología

137 fuentes · 3 capítulos

Obras generales de referencia13
  1. Alberts B, Heald R, Johnson A, Morgan D, Raff M, Roberts K, et al. Molecular biology of the cell. 7th ed. Nueva York: W. W. Norton; 2022.
  2. Lodish H, Berk A, Kaiser CA, Krieger M, Bretscher A, Ploegh H, et al. Molecular cell biology. 9th ed. Nueva York: Macmillan Learning; 2021.
  3. Karp G, Iwasa J, Marshall W. Karp's cell and molecular biology: concepts and experiments. 9th ed. Hoboken (NJ): Wiley; 2020.
  4. Pawlina W. Ross. Histología: texto y atlas. Correlación con biología celular y molecular. 8.ª ed. Barcelona: Wolters Kluwer; 2020.
  5. Mescher AL. Junqueira's basic histology: text and atlas. 16th ed. Nueva York: McGraw Hill; 2021.
  6. Gartner LP. Texto de histología. Atlas a color. 5.ª ed. Barcelona: Elsevier; 2021.
  7. Sadler TW. Langman. Embriología médica. 14.ª ed. Barcelona: Wolters Kluwer; 2019.
  8. Moore KL, Persaud TVN, Torchia MG. Embriología clínica. 11.ª ed. Barcelona: Elsevier; 2020.
  9. Schoenwolf GC, Bleyl SB, Brauer PR, Francis-West PH. Larsen's human embryology. 6th ed. Filadelfia: Elsevier; 2021.
  10. Carlson BM. Human embryology and developmental biology. 6th ed. Filadelfia: Elsevier; 2019.
  11. Barresi MJF, Gilbert SF. Developmental biology. 12th ed. Nueva York: Sinauer Associates/Oxford University Press; 2020.
  12. Federative International Committee on Anatomical Terminology (FICAT). Terminologia histologica: international terms for human cytology and histology. Filadelfia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008.
  13. Federative International Programme for Anatomical Terminology (FIPAT). Terminologia embryologica [Internet]. 2nd ed. FIPAT; 2017.fipat.library.dal.ca
Capítulo 1 · Citología (biología celular)46

Guías, consensos y documentos oficiales

  1. Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486-541. doi: ;doi.orgpublications.wehi.edu.au
  2. Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, et al. Apoptotic cell death in disease—current understanding of the NCCD 2023. Cell Death Differ. 2023;30(5):1097-154. doi:doi.org

Revisiones y artículos

  1. Lonhienne TGA, Sagulenko E, Webb RI, Lee KC, Franke J, Devos DP, et al. Endocytosis-like protein uptake in the bacterium Gemmata obscuriglobus. Proc Natl Acad Sci U S A. 2010;107(29):12883-8. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  2. Santarella-Mellwig R, Pruggnaller S, Roos N, Mattaj IW, Devos DP. Three-dimensional reconstruction of bacteria with a complex endomembrane system. PLoS Biol. 2013;11(5):e1001565. doi:doi.org
  3. Boedeker C, Schüler M, Reintjes G, Jeske O, van Teeseling MC, Jogler M, et al. Determining the bacterial cell biology of Planctomycetes. Nat Commun. 2017;8:14700. doi:doi.org
  4. Amunts A, Brown A, Toots J, Scheres SHW, Ramakrishnan V. The structure of the human mitochondrial ribosome. Science. 2015;348(6230):95-8. doi:doi.org
  5. Levental I, Levental KR, Heberle FA. Lipid rafts: controversies resolved, mysteries remain. Trends Cell Biol. 2020;30(5):341-53. doi:doi.org
  6. De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest. 1995;96(5):2489-95. doi:doi.org
  7. McCulloch LJ, van de Bunt M, Braun M, Frayn KN, Clark A, Gloyn AL. GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus. Mol Genet Metab. 2011;104(4):648-53. doi:doi.org
  8. Wright EM. SGLT2 inhibitors: physiology and pharmacology. Kidney360. 2021;2(12):2027-37. doi:doi.org
  9. Chu M, Gregorio CC, Pappas CT. Nebulin, a multi-functional giant. J Exp Biol. 2016;219(2):146-52. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  10. Crawley SW, Mooseker MS, Tyska MJ. Shaping the intestinal brush border. J Cell Biol. 2014;207(4):441-51. doi: ;doi.orgrupress.org
  11. Meenderink LM, Tyska MJ. Actin dynamics drive microvillar motility and clustering during brush border assembly [preprint]. bioRxiv. 2018. doi:doi.org
  12. Mosalaganti S, Obarska-Kosinska A, Siggel M, Taniguchi R, Turoňová B, Zimmerli CE, et al. AI-based structure prediction empowers integrative structural analysis of human nuclear pores. Science. 2022;376(6598):eabm9506. doi:doi.org
  13. Timney BL, Raveh B, Mironska R, Trivedi JM, Kim SJ, Russel D, et al. Simple rules for passive diffusion through the nuclear pore complex. J Cell Biol. 2016;215(1):57-76. doi: ;doi.orgrupress.org
  14. Lafontaine DLJ, Riback JA, Bascetin R, Brangwynne CP. The nucleolus as a multiphase liquid condensate. Nat Rev Mol Cell Biol. 2021;22(3):165-82. doi: ;doi.orgdipot.ulb.ac.be
  15. Keenan RJ, Freymann DM, Stroud RM, Walter P. The signal recognition particle. Annu Rev Biochem. 2001;70:755-75. doi: ;doi.orgkeenanlab.bsd.uchicago.edu
  16. Farkas Á, Bohnsack KE. Capture and delivery of tail-anchored proteins to the endoplasmic reticulum. J Cell Biol. 2021;220(8):e202105004. doi: ;doi.orgrupress.org
  17. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32(1):81-151. doi:doi.org
  18. Sohn YB. Molecular genetics and diagnostic approach of mucolipidosis II/III. J Mucopolysacch Rare Dis. 2016;2(1):13-6.koreascience.or.kr
  19. Parton RG. Caveolae: structure, function, and relationship to disease. Annu Rev Cell Dev Biol. 2018;34:111-36. doi:doi.org
  20. Kim PK, Mullen RT, Schumann U, Lippincott-Schwartz J. The origin and maintenance of mammalian peroxisomes involves a de novo PEX16-dependent pathway from the ER. J Cell Biol. 2006;173(4):521-32. doi:doi.org
  21. Sugiura A, Mattie S, Prudent J, McBride HM. Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes. Nature. 2017;542(7640):251-4. doi:doi.org
  22. Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49(D1):D1541-7. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  23. Callegari S, Cruz-Zaragoza LD, Rehling P. From TOM to the TIM23 complex – handing over of a precursor. Biol Chem. 2020;401(6-7):709-21. doi:doi.org
  24. Pfanner N, Warscheid B, Wiedemann N. Mitochondrial proteins: from biogenesis to functional networks. Nat Rev Mol Cell Biol. 2019;20(5):267-84. doi:doi.org
  25. Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017;16(12):829-42. doi:doi.org
  26. Narasimha AM, Kaulich M, Shapiro GS, Choi YJ, Sicinski P, Dowdy SF. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. eLife. 2014;3:e02872. doi:doi.org
  27. McVey SL, Cosby JK, Nannas NJ. Aurora B tension sensing mechanisms in the kinetochore ensure accurate chromosome segregation. Int J Mol Sci. 2021;22(16):8818. doi: ;doi.orgmdpi.com
  28. Weir A, Vince JE. No longer married to inflammasome signaling: the diverse interacting pathways leading to pyroptotic cell death. Biochem J. 2022;479(10):1083-102. doi:doi.org
  29. Duo K, Feng X, Tian X, Wang F, Zhao Y, Yu J, et al. Ferroptosis inhibitors: mechanisms of action and therapeutic potential. Cell Mol Life Sci. 2025;82(1):441. doi:doi.org
  30. Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254-61. doi:doi.org
  31. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76. doi:doi.org
  32. Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, et al. Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease. Nature. 2025;641(8064):971-7. doi:doi.org
  33. Pylypenko O, Rak A, Durek T, Kushnir S, Dursina BE, Thomae NH, et al. Structure of doubly prenylated Ypt1:GDI complex and the mechanism of GDI-mediated Rab recycling. EMBO J. 2006;25(1):13-23. doi:doi.org
  34. Gavriljuk K, Itzen A, Goody RS, Gerwert K, Kötting C. Membrane extraction of Rab proteins by GDP dissociation inhibitor characterized using attenuated total reflection infrared spectroscopy. Proc Natl Acad Sci U S A. 2013;110(33):13380-5. doi:doi.org
  35. Mendoza M, Mandani G, Momand J. The MDM2 gene family. Biomol Concepts. 2014;5(1):9-19. doi:doi.org
  36. Brady M, Vlatković N, Boyd MT. Regulation of p53 and MDM2 activity by MTBP. Mol Cell Biol. 2005;25(2):545-53. doi:doi.org

Manuales y monografías

  1. Alberts B, Heald R, Johnson A, Morgan D, Raff M, Roberts K, et al. Molecular biology of the cell. 7th ed. Cap. 12: Intracellular compartments and protein sorting (The transport of molecules between the nucleus and the cytosol) [Internet]. Nueva York: W. W. Norton; 2022.nerd.wwnorton.com
  2. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of the cell. 4th ed. Transport into the cell from the plasma membrane: endocytosis. Nueva York: Garland Science; 2002.ncbi.nlm.nih.gov

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. University of Leeds. The Histology Guide: cell junctions [Internet]. Leeds: Faculty of Biological Sciences, University of Leeds.histology.leeds.ac.uk
  2. RCSB Protein Data Bank. 7R5J: structure of the human nuclear pore complex (Mosalaganti et al., 2022) [Internet].rcsb.org
  3. Online Mendelian Inheritance in Man (OMIM) [Internet]. Baltimore (MD): Johns Hopkins University. MIM 121011 (GJB2, conexina 26).omim.org
  4. Online Mendelian Inheritance in Man (OMIM) [Internet]. Baltimore (MD): Johns Hopkins University. MIM 304040 (Charcot-Marie-Tooth ligada al X tipo 1).omim.org
  5. Online Mendelian Inheritance in Man (OMIM) [Internet]. Baltimore (MD): Johns Hopkins University. MIM 214450 y 607624 (síndrome de Griscelli tipos 1 y 2). ;omim.orgomim.org
  6. Delange J. World's first approval of iPS cell therapies for commercial use. BioNews [Internet]. Londres: Progress Educational Trust; 23 mar 2026.progress.org.uk
Capítulo 2 · Histología41

Guías, consensos y documentos oficiales

  1. Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, et al. Diagnosis and management of Barrett's esophagus: an updated ACG guideline. Am J Gastroenterol. 2022;117(4):559-87. doi:doi.org
  2. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63(1):7-42. doi:doi.org

Revisiones y artículos

  1. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841-5. doi:doi.org
  2. Azevedo FAC, Carvalho LRB, Grinberg LT, Farfel JM, Ferretti REL, Leite REP, et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 2009;513(5):532-41. doi: ;doi.orgpubmed.ncbi.nlm.nih.gov
  3. von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol. 2016;524(18):3865-95. doi: ;doi.orgpubmed.ncbi.nlm.nih.gov
  4. Scarlett JM, Hu SJ, Alonge KM. The «loss» of perineuronal nets in Alzheimer's disease: missing or hiding in plain sight? Front Integr Neurosci. 2022;16:896400. doi: ;doi.orgfrontiersin.org
  5. Anderson PJ, Lynch TJ, Engelhardt JF. Multipotent myoepithelial progenitor cells are born early during airway submucosal gland development. Am J Respir Cell Mol Biol. 2017;56(6):716-26. doi: ;doi.orgiro.uiowa.edu
  6. Singh R, Balasubramanian I, Zhang L, Gao N. Metaplastic Paneth cells in extra-intestinal mucosal niche indicate a link to microbiome and inflammation. Front Physiol. 2020;11:280. doi:doi.org
  7. Stevens RL, Fox CC, Lichtenstein LM, Austen KF. Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc Natl Acad Sci U S A. 1988;85(7):2284-7. doi:doi.org
  8. Metcalfe DD, Bland CE, Wasserman SI. Biochemical and functional characterization of proteoglycans isolated from basophils of patients with chronic myelogenous leukemia. J Immunol. 1984;132(4):1943-50.
  9. Young SG, Fong LG, Beigneux AP, Allan CM, He C, Jiang H, et al. GPIHBP1 and lipoprotein lipase, partners in plasma triglyceride metabolism. Cell Metab. 2019;30(1):51-65. doi:doi.org
  10. Blondin DP, Nielsen S, Kuipers EN, et al. Human brown adipocyte thermogenesis is driven by β2-AR stimulation. Cell Metab. 2020;32(2):287-300.e7. Nota del Novo Nordisk Foundation Center for Basic Metabolic Research (Universidad de Copenhague) [Internet]. doi: ;doi.orgcbmr.ku.dk
  11. Guimarães-Camboa N, Cattaneo P, Sun Y, Moore-Morris T, Gu Y, Dalton ND, et al. Pericytes of multiple organs do not behave as mesenchymal stem cells in vivo. Cell Stem Cell. 2017;20(3):345-59.e5. doi:doi.org
  12. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301-13. doi:doi.org
  13. Hewitt AT, Kleinman HK, Pennypacker JP, Martin GR. Identification of an adhesion factor for chondrocytes. Proc Natl Acad Sci U S A. 1980;77(1):385-8. doi:doi.org
  14. Loeser RF. Integrins and chondrocyte-matrix interactions in articular cartilage. Matrix Biol. 2014;39:11-6. doi:doi.org
  15. Yang L, Tsang KY, Tang HC, Chan D, Cheah KSE. Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation. Proc Natl Acad Sci U S A. 2014;111(33):12097-102. doi: ;doi.orghub.hku.hk
  16. Zhou X, von der Mark K, Henry S, Norton W, Adams H, de Crombrugghe B. Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet. 2014;10(12):e1004820. doi:doi.org
  17. Jacome-Galarza CE, Percin GI, Muller JT, Mass E, Lazarov T, Eitler J, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019;568(7753):541-5. doi: ;doi.orgsynapse.mskcc.org
  18. Lefrançais E, Ortiz-Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544(7648):105-9. doi:doi.org
  19. Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev. 2011;91(4):1447-531. doi:doi.org
  20. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98-102. doi:doi.org
  21. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation. 2014;129(15):1551-9. doi: ;doi.orgpure.psu.edu
  22. Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, Cao W, et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005;436(7054):1181-5. doi:doi.org
  23. Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med. 2012;209(6):1167-81. doi: ;doi.orgrupress.org
  24. Morrison KM, Miesegaes GR, Lumpkin EA, Maricich SM. Mammalian Merkel cells are descended from the epidermal lineage. Dev Biol. 2009;336(1):76-83. doi:doi.org
  25. Van Keymeulen A, Mascre G, Youseff KK, Harel I, Michaux C, De Geest N, et al. Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol. 2009;187(1):91-100. doi:doi.org
  26. Sandilands A, Sutherland C, Irvine AD, McLean WHI. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009;122(Pt 9):1285-94. doi:doi.org
  27. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis. 1982;126(2):332-7. doi:doi.org
  28. Winkelmann A, Noack T. The Clara cell: a «Third Reich eponym»? Eur Respir J. 2010;36(4):722-7. doi:doi.org
  29. Montoro DT, Haber AL, Biton M, Vinarsky V, Lin B, Birket SE, et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes. Nature. 2018;560(7718):319-24. doi:doi.org
  30. Plasschaert LW, Žilionis R, Choo-Wing R, Savova V, Knehr J, Roma G, et al. A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte. Nature. 2018;560(7718):377-81. doi:doi.org
  31. Cornes JS. Number, size, and distribution of Peyer's patches in the human small intestine. Part I: the development of Peyer's patches. Gut. 1965;6(3):225-9. doi:doi.org
  32. Lukacs-Kornek V. The role of lymphatic endothelial cells in liver injury and tumor development. Front Immunol. 2016;7:548. doi: ;doi.orgfrontiersin.org
  33. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A. 2006;103(7):2334-9. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  34. Johansson E, Andersson L, Örnros J, Carlsson T, Ingeson-Carlsson C, Liang S, et al. Revising the embryonic origin of thyroid C cells in mice and humans. Development. 2015;142(20):3519-28. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  35. Furlan A, Dyachuk V, Kastriti ME, Calvo-Enrique L, Abdo H, Hadjab S, et al. Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla. Science. 2017;357(6346):eaal3753. doi:doi.org
  36. Spear GT, French AL, Gilbert D, Zariffard MR, Mirmonsef P, Sullivan TH, et al. Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis. 2014;210(7):1019-28. doi:doi.org
  37. Dua HS, Faraj LA, Said DG, Gray T, Lowe J. Human corneal anatomy redefined: a novel pre-Descemet's layer (Dua's layer). Ophthalmology. 2013;120(9):1778-85. doi:doi.org

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Betts JG, Young KA, Wise JA, Johnson E, Poe B, Kruse DH, et al. Anatomy and physiology 2e. Apartado 10.9: Development and regeneration of muscle tissue [Internet]. Houston (TX): OpenStax; 2022.openstax.org
  2. Harvard Medical School. New lung cell type discovered [Internet]. Boston (MA): Harvard Medical School; 2018.hms.harvard.edu
Capítulo 3 · Embriología37

Guías, consensos y documentos oficiales

  1. Dirección General de Salud Pública, Ministerio de Sanidad y Consumo. Recomendaciones sobre suplementación con ácido fólico para la prevención de defectos del tubo neural. Inf Ter Sist Nac Salud. 2001;25(2):66-7.mirror.mscbs.gob.es
  2. Schweizerische Epilepsie-Liga. Revised folic acid RDA for women with epilepsy: update 2024 [Internet]. Zúrich: Epi-Liga; 2024.epi.ch
  3. European Medicines Agency. Direct healthcare professional communication (DHPC): valproate-containing medicines – new measures regarding potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception [Internet]. Ámsterdam: EMA; 2024.ema.europa.eu
  4. Agenzia Italiana del Farmaco (AIFA). Il PRAC raccomanda nuove misure per evitare l'esposizione del topiramato in gravidanza [Internet]. Roma: AIFA; sep 2023.aifa.gov.it
  5. European Medicines Agency. CellCept (micofenolato de mofetilo): EPAR, ficha técnica, sección 4.6 [Internet]. Ámsterdam: EMA.ema.europa.eu
  6. European Association of Urology. EAU guidelines on paediatric urology: undescended testes [Internet]. Arnhem: EAU.uroweb.org
  7. Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management. Green-top Guideline No. 27a. BJOG. 2019;126(1):e1-48. doi:doi.org
  8. Jasani B, Mitra S, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2022;12(12):CD010061. doi:doi.org

Revisiones y artículos

  1. Kobayashi T, Surani MA. On the origin of the human germline. Development. 2018;145(16):dev150433. doi:doi.org
  2. Heller CG, Clermont Y. Spermatogenesis in man: an estimate of its duration. Science. 1963;140(3563):184-6. doi:doi.org
  3. Amann RP. The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl. 2008;29(5):469-87. doi:doi.org
  4. Schulze W, Rehder U. Organization and morphogenesis of the human seminiferous epithelium. Cell Tissue Res. 1984;237(3):395-407.fis.uke.de
  5. Baibakov B, Boggs NA, Yauger B, Baibakov G, Dean J. Human sperm bind to the N-terminal domain of ZP2 in humanized zonae pellucidae in transgenic mice. J Cell Biol. 2012;197(7):897-905. doi: ;doi.orgscholars.uthscsa.edu
  6. Avella MA, Baibakov B, Dean J. A single domain of the ZP2 zona pellucida protein mediates gamete recognition in mice and humans. J Cell Biol. 2014;205(6):801-9. Comentario: How sperm get into the zona. J Cell Biol. 2014;205(6):754. doi: ;doi.orgrupress.org
  7. Burkart AD, Xiong B, Baibakov B, Jiménez-Movilla M, Dean J. Ovastacin, a cortical granule protease, cleaves ZP2 in the zona pellucida to prevent polyspermy. J Cell Biol. 2012;197(1):37-44. Comentario: Ovastacin cuts off sperm binding. J Cell Biol. 2012;197(1):2. doi: ;doi.orgrupress.org
  8. Gupta SK. Human zona pellucida glycoproteins: binding characteristics with human spermatozoa and induction of acrosome reaction. Front Cell Dev Biol. 2021;9:619868. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  9. Bianchi E, Doe B, Goulding D, Wright GJ. Juno is the egg Izumo receptor and is essential for mammalian fertilization. Nature. 2014;508(7497):483-7. doi:doi.org
  10. Reichmann J, Nijmeijer B, Hossain MJ, Eguren M, Schneider I, Politi AZ, et al. Dual-spindle formation in zygotes keeps parental genomes apart in early mammalian embryos. Science. 2018;361(6398):189-93. Nota de prensa del EMBL [Internet]. doi: ;doi.orgembl.org
  11. Cavazza T, Takeda Y, Politi AZ, Aushev M, Aldag P, Baker C, et al. Parental genome unification is highly error-prone in human zygotes. Cell. 2021;184(11):2860-77.e22. doi:doi.org
  12. Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340(23):1796-9. doi:doi.org
  13. Semrl N, Barth M, Feigl S, Hochstätter R, Oreskovic I, Fluhr H, et al. Birth of monozygotic dichorionic twins after a single blastocyst embryo transfer: a case report of genetic determination of zygosity. 2023 [Internet].doaj.org
  14. Ivanovs A, Rybtsov S, Welch L, Anderson RA, Turner ML, Medvinsky A. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J Exp Med. 2011;208(12):2417-27. doi: ;doi.orgrupress.org
  15. Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015;518(7540):547-51. doi:doi.org
  16. Guijarro C, Kelly RG. On the involvement of the second heart field in congenital heart defects. C R Biol. 2024;347:9-18. doi: ;doi.orgcomptes-rendus.academie-sciences.fr
  17. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469(7330):415-8. doi:doi.org
  18. Hanley NA, Hagan DM, Clement-Jones M, Ball SG, Strachan T, Salas-Cortés L, et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mech Dev. 2000;91(1-2):403-7.pubmed.ncbi.nlm.nih.gov
  19. von Cube C, Schmidt A, Krönninger M, Hrivatakis G, Astfalk W, Fuchs J, et al. A closer look to the timing of orchidopexy in undescended testes and adherence to the AWMF-guideline. Pediatr Surg Int. 2024;40:60. doi:doi.org
  20. Vegrim HM, Dreier JW, Alvestad S, Gilhus NE, Gissler M, Igland J, et al. Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy. JAMA Neurol. 2022;79(11). doi:doi.org
  21. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen. 2002;9(1):2-6. doi:doi.org

Manuales y monografías

  1. Patent ductus arteriosus. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.statpearls.com
  2. Manual MSD, versión para profesionales. Ventricular septal defect (VSD) [Internet]. Rahway (NJ): Merck & Co.msdmanuals.com
  3. MedlinePlus Genetics. Swyer syndrome [Internet]. Bethesda (MD): National Library of Medicine.medlineplus.gov

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Embryology.ch. Formation of the neural tube [Internet]. Universidades de Friburgo, Lausana y Berna.embryology.ch
  2. University of Minnesota, Visible Heart Laboratories. Atlas of human cardiac anatomy: patent ductus arteriosus [Internet]. Minneapolis (MN): University of Minnesota.vhlab.umn.edu
  3. York and Scarborough Teaching Hospitals NHS Foundation Trust. Human chorionic gonadotropin [Internet]. York: NHS.yorkhospitals.nhs.uk
  4. MGH Center for Women's Mental Health. Fact sheet: valproic acid (Depakote) and pregnancy [Internet]. Boston (MA): Massachusetts General Hospital.womensmentalhealth.org
  5. BioNumbers. Duration of the whole spermatogenesis in man. BNID 110319 [Internet]. Boston (MA): Harvard Medical School.bionumbers.hms.harvard.edu

Fecha de consulta: 27 de octubre de 2026.

Estadística y Técnicas instrumentales

83 fuentes · 2 capítulos

Obras generales de referencia12
  1. Martínez-González MA, Sánchez-Villegas A, Toledo Atucha E, Faulin Fajardo J, editores. Bioestadística amigable. 4.ª ed. Barcelona: Elsevier; 2020.
  2. Altman DG. Practical statistics for medical research. Londres: Chapman & Hall; 1991.
  3. Bland M. An introduction to medical statistics. 4th ed. Oxford: Oxford University Press; 2015.
  4. Lash TL, VanderWeele TJ, Haneuse S, Rothman KJ. Modern epidemiology. 4th ed. Filadelfia: Wolters Kluwer; 2021.
  5. Milton JS. Estadística para biología y ciencias de la salud. 3.ª ed. ampliada. Madrid: McGraw-Hill/Interamericana de España; 2007.
  6. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editores. Cochrane handbook for systematic reviews of interventions. Versión 6.5 [Internet]. Londres: Cochrane; 2024.training.cochrane.org
  7. Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, editores. Tietz textbook of laboratory medicine. 7th ed. St. Louis: Elsevier; 2023.
  8. McPherson RA, Pincus MR, editores. Henry's clinical diagnosis and management by laboratory methods. 24th ed. St. Louis: Elsevier; 2021.
  9. Green MR, Sambrook J. Molecular cloning: a laboratory manual. 4th ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2012.
  10. Alberts B, Heald R, Johnson A, Morgan D, Raff M, Roberts K, et al. Molecular biology of the cell. 7th ed. Nueva York: W. W. Norton & Company; 2022.
  11. Abbas AK, Lichtman AH, Pillai S, Henrickson S. Cellular and molecular immunology. 11th ed. Filadelfia: Elsevier; 2025.
  12. González de Buitrago JM. Técnicas y métodos de laboratorio clínico. 3.ª ed. Barcelona: Elsevier Masson; 2010.
Capítulo 1 · Estadística y epidemiología32

Guías, consensos y documentos oficiales

  1. Hopewell S, Chan AW, Collins GS, Hróbjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123. doi: ; ;doi.orgpmc.ncbi.nlm.nih.govwrap.warwick.ac.uk
  2. Chan AW, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 statement: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081477. doi:doi.org
  3. Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-604. doi:doi.org
  4. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. doi:doi.org
  5. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  6. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. doi:doi.org
  7. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6. doi:doi.org
  8. Centers for Disease Control and Prevention. ACIP GRADE handbook. Chapter 7: GRADE criteria determining certainty of evidence [Internet]. Atlanta: CDC.cdc.gov
  9. Wasserstein RL, Lazar NA. The ASA statement on p-values: context, process, and purpose. Am Stat. 2016;70(2):129-33. doi:doi.org
  10. Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond «p < 0.05». Am Stat. 2019;73(Suppl 1):1-19. doi:doi.org
  11. Ryan R; Cochrane Consumers and Communication Review Group. Heterogeneity and subgroup analyses in Cochrane Consumers and Communication Group reviews: planning the analysis at protocol stage [Internet]. Cochrane; 2016.cccrg.cochrane.org
  12. NIST/SEMATECH. e-Handbook of statistical methods. 1.3.5.11. Measures of skewness and kurtosis [Internet]. Gaithersburg (MD): National Institute of Standards and Technology.itl.nist.gov
  13. NIST/SEMATECH. e-Handbook of statistical methods. 7.1.6. What are outliers in the data? [Internet]. Gaithersburg (MD): National Institute of Standards and Technology.itl.nist.gov

Revisiones y artículos

  1. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74. doi:doi.org
  2. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76(5):378-82. doi:doi.org
  3. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. doi:doi.org
  4. Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi:doi.org
  5. Cochran WG. Some methods for strengthening the common χ2 tests. Biometrics. 1954;10(4):417-51. doi:doi.org
  6. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36. doi:doi.org
  7. Jaeschke R, Guyatt GH, Sackett DL; Evidence-Based Medicine Working Group. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA. 1994;271(9):703-7. doi:doi.org
  8. Altman DG. Confidence intervals for the number needed to treat. BMJ. 1998;317(7168):1309-12. doi:doi.org
  9. Westfall PH. Kurtosis as peakedness, 1905–2014. R.I.P. Am Stat. 2014;68(3):191-5. doi: ;doi.orgideas.repec.org
  10. von Hippel PT. Mean, median, and skew: correcting a textbook rule. J Stat Educ. 2005;13(2). doi: ;doi.orgjse.amstat.org
  11. Gates TJ. Screening for cancer: concepts and controversies. Am Fam Physician. 2014;90(9):625-31.aafp.org
  12. Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010;37(3):202-15. doi:doi.org

Manuales y monografías

  1. Kleinbaum DG, Klein M. Survival analysis: a self-learning text. 3rd ed. Nueva York: Springer; 2012.
  2. Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken (NJ): Wiley; 2013.
  3. Conover WJ. Practical nonparametric statistics. 3rd ed. Nueva York: Wiley; 1999.

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Asociación Española de Pediatría. Evaluación de la validez de las pruebas diagnósticas [Internet]. Madrid: AEP.aeped.es
  2. Pita Fernández S, Pértegas Díaz S. Metodología de la investigación (pruebas diagnósticas, tamaño muestral, pruebas paramétricas y no paramétricas) [Internet]. A Coruña: Fisterra.fisterra.com
  3. MRC Cognition and Brain Sciences Unit. Statswiki. FAQ: kappa, magnitude guidelines [Internet]. Cambridge: University of Cambridge. Resume Landis y Koch (1977).imaging.mrc-cbu.cam.ac.uk
  4. Indiana University, Indiana Statistical Consulting Center. ASA statement on statistical significance and p-values (resumen de los seis principios) [Internet]. Bloomington (IN): Indiana University.iscc.indiana.edu
Capítulo 2 · Técnicas instrumentales y control de calidad39

Normas, guías, consensos y documentos oficiales

  1. International Organization for Standardization. ISO 15189:2022. Medical laboratories — Requirements for quality and competence. 4th ed. Ginebra: ISO; 2022.
  2. Joint Committee for Guides in Metrology. International vocabulary of metrology — basic and general concepts and associated terms (VIM). 3rd ed. JCGM 200:2012. Sèvres: BIPM; 2012.
  3. Clinical and Laboratory Standards Institute. Statistical quality control for quantitative measurement procedures: principles and definitions. 4th ed. CLSI guideline C24. Wayne (PA): CLSI; 2016.
  4. Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G, Oosterhuis W, et al. Defining analytical performance specifications: consensus statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2015;53(6):833-5. doi:doi.org
  5. Ceriotti F, Fernandez-Calle P, Klee GG, Nordin G, Sandberg S, Streichert T, et al. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clin Chem Lab Med. 2017;55(2):189-95. doi: ;doi.orgsites.unimi.it
  6. European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). EFLM Biological Variation Database [Internet]. Milán: EFLM.biologicalvariation.eu
  7. International Laboratory Accreditation Cooperation (ILAC). ISO 15189:2022 for medical labs published [Internet]. 8 dic 2022.ilac.org
  8. Entidad Nacional de Acreditación (ENAC). Transition plan ISO 15189:2022 [Internet]. Madrid: ENAC.enac.es
  9. Eurachem Education and Training Working Group. ISO 15189:2022 – A new task for medical laboratories [folleto en Internet]. Eurachem; 2024.eurachem.org
  10. Organización Mundial de la Salud. New INN monoclonal antibody (mAb) nomenclature scheme. INN Working Document 22.542 [Internet]. Ginebra: OMS; 2022.who.int
  11. Organización Panamericana de la Salud. La OMS recomienda a los países que dejen de utilizar pruebas Western blot e inmunoensayos en línea [Internet]. Washington D. C.: OPS; 30 nov 2019.paho.org
  12. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep. 2019;68(32):703. doi: ;doi.orgcdc.gov
  13. U.S. Food and Drug Administration. Biotin interference with troponin lab tests: assays subject to biotin interference [Internet]. Silver Spring (MD): FDA; 2019.fda.gov
  14. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(11):2029-37. doi:doi.org
  15. European Medicines Agency. Casgevy (exagamglogén autotemcel): EPAR [Internet]. Ámsterdam: EMA.ema.europa.eu
  16. European Association of Urology. EAU guidelines on urolithiasis [Internet]. Arnhem: EAU.uroweb.org
  17. Ryan K, Bain BJ, Worthington D, James J, Plews D, Mason A, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010;149(1):35-49. doi:doi.org
  18. Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase. Clin Chem Lab Med. 2002;40(6):643-8. doi:doi.org
  19. Centers for Disease Control and Prevention. Laboratory procedure manual: lead and cadmium in whole blood (ICP-DRC-MS, método 3001.1). NHANES 2009–2010 [Internet]. Atlanta: CDC.wwwn.cdc.gov

Revisiones y artículos

  1. Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981;27(3):493-501. doi:doi.org
  2. Westgard S, Bayat H. Reply to Christelli et al.: Implementation of new Westgard Rules suggested by the Westgard Advisor software for five immunological parameters. What Six Sigma, quality control, the analytical Sigma-metric, and Westgard Advisor can and cannot do. Biochem Med (Zagreb). 2025;35(2):020401. doi: ;doi.orgbiochemia-medica.com
  3. Horvath AR, Bell KJL, Ceriotti F, Jones GRD, Loh TP, Lord S, et al. Outcome-based analytical performance specifications: current status and future challenges. Clin Chem Lab Med. 2024;62(8):1474-82. doi:doi.org
  4. Sandberg S, Coskun A, Carobene A, Fernandez-Calle P, Diaz-Garzon J, Bartlett WA, et al. Analytical performance specifications based on biological variation data – considerations, strengths and limitations. Clin Chem Lab Med. 2024;62(8):1483-9. doi:doi.org
  5. Carraro P, Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem. 2007;53(7):1338-42. doi:doi.org
  6. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev. 2004;25(2):105-20.pmc.ncbi.nlm.nih.gov
  7. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495-7. doi:doi.org
  8. Klenow H, Henningsen I. Selective elimination of the exonuclease activity of the deoxyribonucleic acid polymerase from Escherichia coli B by limited proteolysis. Proc Natl Acad Sci U S A. 1970;65(1):168-75. doi: ;doi.orgpolbase.neb.com
  9. Green MR, Sambrook J. E. coli DNA polymerase I and the Klenow fragment. Cold Spring Harb Protoc. 2020;2020(5):pdb.top100743. doi: ;doi.orgcshprotocols.cshlp.org
  10. Guimaraes Koch SS, Thorpe R, Kawasaki N, Lefranc MP, Malan S, Martin ACR, et al. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system. mAbs. 2022;14(1):2075078. doi:doi.org
  11. Lee PY, Costumbrado J, Hsu CY, Kim YH. Agarose gel electrophoresis for the separation of DNA fragments. J Vis Exp. 2012;(62):3923. doi: ;doi.orgpmc.ncbi.nlm.nih.gov
  12. Clark AE, Kaleta EJ, Arora A, Wolk DM. Matrix-assisted laser desorption ionization–time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev. 2013;26(3):547-603. doi:doi.org
  13. Wenger AM, Peluso P, Rowell WJ, Chang PC, Hall RJ, Concepcion GT, et al. Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome. Nat Biotechnol. 2019;37(10):1155-62. doi:doi.org

Otras fuentes consultadas (material docente, divulgación y notas de prensa)

  1. Westgard QC. Westgard Sigma Rules [Internet]. Madison (WI): Westgard QC.westgard.com
  2. Nobel Prize Outreach. The Nobel Prize in Physiology or Medicine 1977 [Internet]. Estocolmo: NobelPrize.org.nobelprize.org
  3. Promega. DNA Polymerase I, Large (Klenow) Fragment: ficha técnica [Internet]. Madison (WI): Promega.promega.jp
  4. University of Tartu. LC-MS method validation. 4.1. Precision, trueness, accuracy [curso en Internet]. Tartu: University of Tartu.sisu.ut.ee
  5. The Hospital for Sick Children (SickKids). Angelman syndrome: laboratory information sheet [Internet]. Toronto: SickKids.inte.sickkids.ca
  6. valytics (paquete de R, CRAN). Setting quality goals with biological variation [viñeta en Internet].archive.linux.duke.edu
  7. African Society for Laboratory Medicine (ASLM). Changes and impact of ISO 15189:2022 [Internet]. Adís Abeba: ASLM; 2023.old.aslm.org

Fecha de consulta: 27 de octubre de 2026.

No hay ninguna fuente con ese texto.